: The AMEDEO Literature Guide

Home The Word Brain

My Amedeo

FAQ

Privacy

About

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

HIV Infection

Free Subscription

Articles published in HIV Med
Retrieve available abstracts of 384 articles:
HTML format

Single Articles

May 2024

KATLAMA C, Bisshop F, Bogner J, Perez Elias MJ, et al
Efficacy and safety of dolutegravir/lamivudine in virologically suppressed female participants: week 48 data from the pooled TANGO and SALSA studies.
HIV Med. 2024 May 17. doi: 10.1111/hiv.13643.
PubMed Abstract available

LOGIE CH, Sokolovic N, Casale A, Ndung'u M, et al
Clinical HIV outcome trajectories associated with a history of child protective service out-of-home care: Longitudinal cohort findings with women living with HIV in Canada.
HIV Med. 2024 May 17. doi: 10.1111/hiv.13660.
PubMed Abstract available

LUMBRERAS ARETA M, Migliorelli Falcone FE, Rudin C, Kahlert CR, et al
Trends in preterm birth in women living with HIV in Switzerland over the last three decades: A multicentric, prospective, cohort study.
HIV Med. 2024 May 16. doi: 10.1111/hiv.13652.
PubMed Abstract available

BUSCA-ARENZANA C, Ortega-Gonzalez D, Diaz-Almiron M, Montes ML, et al
Metabolic effects of switching to Biktarvy (B/F/TAF) in patients with HIV-1 treated with antiretroviral regimens that do not include tenofovir disoproxil fumarate (TDF) or tenofovir alafenamide (TAF): The Metabic study.
HIV Med. 2024 May 15. doi: 10.1111/hiv.13659.
PubMed Abstract available

NAKAMURA H, Yamamoto K
Mpox in people with HIV: A narrative review.
HIV Med. 2024 May 15. doi: 10.1111/hiv.13661.
PubMed Abstract available

BROWN L, Sargent P, Islam M, Downie C, et al
Severe ocular Mpox in person living with advanced HIV treated with extended course of tecovirimat.
HIV Med. 2024 May 9. doi: 10.1111/hiv.13656.
PubMed Abstract available

FINLAYSON-TRICK E, Tam C, Wang L, Dawydiuk N, et al
Access to care and impact on HIV treatment interruptions during the COVID-19 pandemic among people living with HIV in British Columbia.
HIV Med. 2024 May 9. doi: 10.1111/hiv.13654.
PubMed Abstract available

MATACOTTA JJ, Tran D, Yoon S
The prevalence of major depressive disorder in people with HIV: Results from the All of Us Research Program.
HIV Med. 2024 May 7. doi: 10.1111/hiv.13653.
PubMed Abstract available

OOSTERHOF P, de Zoete BGJA, Vanhommerig JW, Langebeek N, et al
De-simplifying antiretroviral therapy from a single-tablet to a two-tablet regimen: Acceptance, patient-reported outcomes, and cost savings in a multicentre study.
HIV Med. 2024 May 7. doi: 10.1111/hiv.13655.
PubMed Abstract available

April 2024

LLIBRE JM, Garcia F, Blanco JL, Pelaez EP, et al
Prevalence of people living with multidrug-resistant HIV and limited treatment options in Spain.
HIV Med. 2024 Apr 30. doi: 10.1111/hiv.13650.
PubMed Abstract available

DINESHA TR, Boobalan J, Kumar CV, Manikandan P, et al
HIV-1 low-level viraemia predicts virological failure in first-line and second-line ART-experienced individuals in India: A retrospective longitudinal study.
HIV Med. 2024 Apr 25. doi: 10.1111/hiv.13641.
PubMed Abstract available

BULLO M, Kierszenowicz T, Acosta MC, Rolon MJ, et al
Telemedicine in HIV health care during the COVID-19 pandemic: An implementation research study in Buenos Aires, Argentina.
HIV Med. 2024 Apr 24. doi: 10.1111/hiv.13646.
PubMed Abstract available

JOHN M, Williams L, Nolan G, Bonnett M, et al
Real-world use of long-acting cabotegravir and rilpivirine: 12-month results of the inJectable Antiretroviral therapy feasiBility Study (JABS).
HIV Med. 2024 Apr 21. doi: 10.1111/hiv.13647.
PubMed Abstract available

DEMA E, Peters H, Gilleece Y, Thorne C, et al
Residential and healthcare mobility during pregnancy among women living with HIV in the UK, 2009-2019.
HIV Med. 2024 Apr 10. doi: 10.1111/hiv.13648.
PubMed Abstract available

OZHMEGOVA E, Lebedev A, Antonova A, Kuznetsova A, et al
Prevalence of HIV drug resistance at antiretroviral treatment failure across regions of Russia.
HIV Med. 2024 Apr 7. doi: 10.1111/hiv.13642.
PubMed Abstract available

CALZA L, Giglia M, Colangeli V, Bon I, et al
Improvement in insulin sensitivity after switching from an integrase inhibitor-based regimen to doravirine/tenofovir disoproxil fumarate/lamivudine in people with significant weight gain.
HIV Med. 2024 Apr 3. doi: 10.1111/hiv.13644.
PubMed Abstract available

BHIVA Spring Conference 2024, Birmingham, 29 April - 1 May 2024.
HIV Med. 2024;25 Suppl 1:21-111.
PubMed

BHIVA Spring Conference 2024, Birmingham, 29 April - 1 May 2024.
HIV Med. 2024;25 Suppl 1:3-16.
PubMed

BHIVA Spring Conference 2024, Birmingham, 29 April - 1 May 2024.
HIV Med. 2024;25 Suppl 1:17-20.
PubMed

March 2024

LIU Y, Cheng Z, Xian Y, Liu X, et al
Cascade analysis of awareness, willingness, uptake and adherence with regard to PrEP among young men who have sex with men (YMSM) in China: A comparison between students and non-students.
HIV Med. 2024 Mar 27. doi: 10.1111/hiv.13639.
PubMed Abstract available

OTTAWAY Z, Campbell L, Fox J, Burns F, et al
HIV outcomes during the COVID-19 pandemic in people of Black ethnicities living with HIV in England.
HIV Med. 2024 Mar 26. doi: 10.1111/hiv.13640.
PubMed Abstract available

SAWRY S, Ayalew K, Maimela G, Briggs-Hagen M, et al
Assessment of weight gain in adult patients living with HIV receiving first-line dolutegravir-based or efavirenz-based ART regimens in routine care clinics in Tshwane district, South Africa: An observational study.
HIV Med. 2024 Mar 22. doi: 10.1111/hiv.13638.
PubMed Abstract available

ZOU S, Chen Z, Tan Y, Tan M, et al
Microbiomes detected by cerebrospinal fluid metagenomic next-generation sequencing among patients with and without HIV with suspected central nervous system infection.
HIV Med. 2024 Mar 21. doi: 10.1111/hiv.13634.
PubMed Abstract available

SOCIAS ME, Cui Z, Le Foll B, Lei J, et al
Sexually transmitted and blood-borne infection risk reduction with methadone and buprenorphine/naloxone among people with prescription-type opioid use disorder: Findings from a Canadian pragmatic randomized trial.
HIV Med. 2024 Mar 20. doi: 10.1111/hiv.13636.
PubMed Abstract available

JACOBS TG, Okemo D, Ssebagereka A, Mwehonge K, et al
Availability and stock-outs of paediatric antiretroviral treatment formulations at health facilities in Kenya and Uganda.
HIV Med. 2024 Mar 18. doi: 10.1111/hiv.13635.
PubMed Abstract available

DOU Y, Lu R, Su L, Lan K, et al
Efficacy of dolutegravir + lamivudine q.d. with food in people with TB/HIV using a rifampicin-based regimen: A retrospective observational case series.
HIV Med. 2024 Mar 17. doi: 10.1111/hiv.13632.
PubMed Abstract available

VIOLETTE LR, Thomas KK, Dorward J, Quame-Amaglo J, et al
Early HIV viral suppression associated with subsequent 12-month treatment success among people living with HIV in South Africa.
HIV Med. 2024 Mar 15. doi: 10.1111/hiv.13633.
PubMed Abstract available

ZHAO J, Zhang L, Li L, Xie X, et al
Growth of infants delivered by mothers with HIV in Guangxi, China: An 18-month longitudinal follow-up study, 2015-2021.
HIV Med. 2024 Mar 13. doi: 10.1111/hiv.13624.
PubMed Abstract available

TAHA AM, Elrosasy A, Mahmoud AM, Saed SAA, et al
The effect of HIV and mpox co-infection on clinical outcomes: Systematic review and meta-analysis.
HIV Med. 2024 Mar 5. doi: 10.1111/hiv.13622.
PubMed Abstract available

PALICH R, Rodger AJ, Nicholls EJ, Wright T, et al
Experiences with health care services and HIV testing after sexual assault in cisgender gay, bisexual and other men who have sex with men and transgender people.
HIV Med. 2024 Mar 3. doi: 10.1111/hiv.13629.
PubMed Abstract available

FURSA O, Bannister W, Neesgaard B, Podlekareva D, et al
SARS-CoV-2 testing, positivity, and factors associated with COVID-19 among people with HIV across Europe in the multinational EuroSIDA cohort.
HIV Med. 2024 Mar 3. doi: 10.1111/hiv.13620.
PubMed Abstract available

NOE S, Ivanova A, Johnsson-Oldenbuttel C, Schafer G, et al
Immunological alterations with GLP-1 agonists in people living with HIV.
HIV Med. 2024 Mar 3. doi: 10.1111/hiv.13631.
PubMed

February 2024

HOLROYD KB, Han WM, Apornpong T, Trautmann L, et al
Framingham risk score based vascular outcomes in acute versus chronic HIV cohorts after 6 years of ART.
HIV Med. 2024 Feb 21. doi: 10.1111/hiv.13621.
PubMed Abstract available

RAMOS-RUPERTO L, Arcos-Rueda MDM, de Miguel-Buckley R, Busca-Arenzana C, et al
Sex differences in the effectiveness and tolerability of dolutegravir plus rilpivirine as a switch strategy in people living with HIV.
HIV Med. 2024 Feb 20. doi: 10.1111/hiv.13617.
PubMed Abstract available

KLEEBAYOON A, Wiwanitkit V
Asymptomatic monkeypox infection and highly sexually active MSM population.
HIV Med. 2024 Feb 20. doi: 10.1111/hiv.13623.
PubMed

KRAEF C, Singh S, Fursa O, Abutidze A, et al
Differences in integrated assessment and management of non-communicable diseases (NCDs) for people with HIV across the WHO European region.
HIV Med. 2024 Feb 15. doi: 10.1111/hiv.13619.
PubMed Abstract available

XU X, Andersson E, Rahbar A, Soderberg-Naucler C, et al
Cytomegalovirus infection among people living with HIV in Sweden: Case profiles, treatment strategies and patient outcomes at Karolinska University Hospital 2010-2020.
HIV Med. 2024 Feb 13. doi: 10.1111/hiv.13618.
PubMed Abstract available

January 2024

ENGLER K, Avallone F, Cadri A, Lebouche B, et al
Patient-reported outcome measures in adult HIV care: A rapid scoping review of targeted outcomes and instruments used.
HIV Med. 2024 Jan 28. doi: 10.1111/hiv.13599.
PubMed Abstract available

RYSCAVAGE P, Hussien S, Seung H, Hynicka L, et al
CD4+ T-cell recovery in HIV/hepatitis C co-infected patients following successful hepatitis C treatment.
HIV Med. 2024 Jan 25. doi: 10.1111/hiv.13612.
PubMed Abstract available

ROSSOTTI R, D'Amico F, Bana NB, Nava A, et al
Durability of doravirine with dolutegravir dual regimen compared with other dolutegravir-based dual combinations.
HIV Med. 2024 Jan 23. doi: 10.1111/hiv.13615.
PubMed Abstract available

FERNANDEZ-FRADEJAS J, Delgado-Silveira E, Gonzalez-Burgos E, Alvarez-Diaz AM, et al
Potentially inappropriate prescriptions and potential prescription omissions in older people living with HIV.
HIV Med. 2024 Jan 23. doi: 10.1111/hiv.13616.
PubMed Abstract available

AYANFUL-TORGBY R, Shabanova V, Essuman AA, Boafo E, et al
High prevalence of impaired glucose metabolism among children and adolescents living with HIV in Ghana.
HIV Med. 2024 Jan 19. doi: 10.1111/hiv.13614.
PubMed Abstract available

KRENTZ HB, Lang R, McMillan J, Ody M, et al
The changing landscape of both causes and locations of death in a regional HIV population 2010-2021.
HIV Med. 2024 Jan 19. doi: 10.1111/hiv.13610.
PubMed Abstract available

KRANKOWSKA D, Mazzitelli M, Ucak HA, Orviz E, et al
Screening and prevention of HPV-related anogenital cancers in women living with HIV in Europe: Results from a systematic review.
HIV Med. 2024 Jan 18. doi: 10.1111/hiv.13602.
PubMed Abstract available

GALINDO PUERTO MJ, Puig J, Perez-Molina JA, Fuster-Ruiz de Apodaca MJ, et al
Perspectives of people with HIV and HIV clinicians on characteristics of antiretroviral treatment and HIV-related symptoms.
HIV Med. 2024 Jan 12. doi: 10.1111/hiv.13609.
PubMed Abstract available

OTTAWAY Z, Campbell L, Cechin LR, Patel N, et al
Clinical epidemiology of COVID-19 in people of black ethnicity living with HIV in the UK.
HIV Med. 2024 Jan 11. doi: 10.1111/hiv.13611.
PubMed Abstract available

ARORA AK, Vicente S, Engler K, Lessard D, et al
Impact of social determinants of health on time to antiretroviral therapy initiation and HIV viral undetectability for migrants enrolled in a multidisciplinary HIV clinic with rapid, free, and onsite B/F/TAF: 'The ASAP study'.
HIV Med. 2024 Jan 11. doi: 10.1111/hiv.13608.
PubMed Abstract available

KRANKOWSKA DC, Lourida P, Quirke SM, Woode Owusu M, et al
Barriers to HIV testing and possible interventions to improve access to HIV healthcare among migrants, with a focus on migrant women: Results from a European survey.
HIV Med. 2024 Jan 10. doi: 10.1111/hiv.13606.
PubMed Abstract available

LINDH M, Brannstrom J, Reepalu A, Svedhem V, et al
Factors associated with sex differences in viral non-suppression in the Swedish InfCareHIV cohort: An observational real-world study.
HIV Med. 2024 Jan 9. doi: 10.1111/hiv.13607.
PubMed Abstract available

KOH MCY, Ngiam JN, Yong J, Tambyah PA, et al
The role of an artificial intelligence model in antiretroviral therapy counselling and advice for people living with HIV.
HIV Med. 2024 Jan 2. doi: 10.1111/hiv.13604.
PubMed Abstract available

December 2023

OKUSANYA TR, Okoka EM, Kuyebi MA, Oyadiran OT, et al
Nutrition counselling and clinical outcomes in HIV: A systematic review and meta-analysis.
HIV Med. 2023 Dec 29. doi: 10.1111/hiv.13603.
PubMed Abstract available

LIU M, He K, Wu Y, Yu Q, et al
Prevalence of, risk factors for, and target organ damage from metabolic syndrome among people living with HIV on ART: A cross-sectional analysis in Chongqing, China.
HIV Med. 2023 Dec 29. doi: 10.1111/hiv.13605.
PubMed Abstract available

ESSER S, Brunetta J, Inciarte A, Levy I, et al
Twelve-month effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide in people with HIV: Real-world insights from BICSTaR cohorts.
HIV Med. 2023 Dec 26. doi: 10.1111/hiv.13593.
PubMed Abstract available

OKA S, Holohan V, Shirasaka T, Choi JY, et al
Asian participants' experience in phase 3/3b studies of long-acting cabotegravir and rilpivirine: Efficacy, safety, pharmacokinetic, and virological outcomes through week 96.
HIV Med. 2023 Dec 26. doi: 10.1111/hiv.13588.
PubMed Abstract available

DAULTREY H, Levett T, Oliver N, Vera J, et al
HIV and type 2 diabetes: An evolving story.
HIV Med. 2023 Dec 18. doi: 10.1111/hiv.13595.
PubMed Abstract available

RANZANI A, Castelli F, Di Biagio A, d'Arminio Monforte A, et al
Influence of efavirenz and 8-hydroxy-efavirenz plasma levels on cognition and central nervous system side effects.
HIV Med. 2023 Dec 17. doi: 10.1111/hiv.13600.
PubMed Abstract available

BRUGUERA A, Egea-Cortes L, Mesias-Gazmuri J, Palacio-Vieira J, et al
Predictors of poor health-related quality of life among people living with HIV aged >/=60 years in the PISCIS cohort: Findings from the Vive+ project.
HIV Med. 2023 Dec 13. doi: 10.1111/hiv.13590.
PubMed Abstract available

MCGEE DM, Cotter AG
HIV and fracture: Risk, assessment and intervention.
HIV Med. 2023 Dec 12. doi: 10.1111/hiv.13596.
PubMed Abstract available

AKMATOV MK, Hu E, Rusenberg R, Kollan C, et al
Areas with high HIV prevalence: A spatial analysis of nationwide claims data in Germany.
HIV Med. 2023 Dec 10. doi: 10.1111/hiv.13601.
PubMed Abstract available

CLAIR-SULLIVAN NS, Bristowe K, Khan I, Maddocks M, et al
Implementation of frailty screening for older people living with HIV in Brighton, UK.
HIV Med. 2023 Dec 7. doi: 10.1111/hiv.13598.
PubMed Abstract available

AHRENSTORF G, Dopfer-Jablonka A, Joean O, Knuth C, et al
Status of HIV and comorbidities in refugees with HIV from Ukraine.
HIV Med. 2023 Dec 3. doi: 10.1111/hiv.13597.
PubMed Abstract available

LIEGEON G, Duffy A, Brooks C, Honour H, et al
HIV pre-exposure prophylaxis services, provision, and delivery in the European treatment network of HIV, hepatitis and global emerging infectious diseases (NEAT ID).
HIV Med. 2023 Dec 1. doi: 10.1111/hiv.13580.
PubMed Abstract available

Abstracts of the 19th European AIDS Conference (#EACS2023), October 18-21, 2023, Warsaw, Poland.
HIV Med. 2023;24 Suppl 5:3-788.
PubMed

POLICEK N, Mendao L
Tackling ageism in the healthcare system: A community perspective.
HIV Med. 2023;24:1172-1175.
PubMed

November 2023

LECLERC E, Jacomet C, Siproudhis L, Abramowitz L, et al
Impact of screening programme to prevent anal cancer in high-risk patients with HIV.
HIV Med. 2023 Nov 30. doi: 10.1111/hiv.13594.
PubMed Abstract available

KEANE A, Lyons F, Aebi-Popp K, Feiterna-Sperling C, et al
Guidelines and practice of breastfeeding in women living with HIV-Results from the European INSURE survey.
HIV Med. 2023 Nov 29. doi: 10.1111/hiv.13583.
PubMed Abstract available

OPREA C, Quirke S, Ianache I, Bursa D, et al
HIV disease metrics and COVID-19 infection severity and outcomes in people living with HIV in central and eastern Europe.
HIV Med. 2023 Nov 28. doi: 10.1111/hiv.13578.
PubMed Abstract available

SAN FRANCISCO RAMOS A, Isitt C, Athaide S, Ladhani SN, et al
Propositive follow-up: Long-term immune responses to the 4CMenB and MenACWY vaccines in people living with HIV.
HIV Med. 2023 Nov 28. doi: 10.1111/hiv.13586.
PubMed Abstract available

HILL L, Thompson C, Balcombe S, Jain S, et al
Effects of a hospital discharge clinic among people with HIV: Lack of early follow-up is associated with 30-day hospital readmission and decreased retention in care.
HIV Med. 2023 Nov 27. doi: 10.1111/hiv.13577.
PubMed Abstract available

TREVILLYAN JM, Behrens G
Ageing with HIV; a victory, a challenge and a call to action.
HIV Med. 2023 Nov 22. doi: 10.1111/hiv.13591.
PubMed

DAWE J, Cassano D, Keane R, Ruth S, et al
Quality of life among people living with HIV aged 50 years and over in Australia: Identifying opportunities to support better ageing.
HIV Med. 2023 Nov 22. doi: 10.1111/hiv.13592.
PubMed Abstract available

SHI J, Ying G, Zheng R, Zhang Z, et al
Clinical significance and management of low-level HIV viremia in the era of integrase strand transfer inhibitors.
HIV Med. 2023 Nov 22. doi: 10.1111/hiv.13585.
PubMed Abstract available

LU L, Ma Y, Cong Y, Zhou B, et al
Comorbidity of Myasthenia gravis and Graves' disease as immune reconstitution-associated autoimmune disease in HIV infection: A case report and literature review.
HIV Med. 2023 Nov 22. doi: 10.1111/hiv.13584.
PubMed Abstract available

ALFORD K, Sidat S, Bristowe K, St Clair-Sullivan N, et al
People with HIV and healthcare workers views on screening for cognitive impairment in people with HIV: A qualitative study.
HIV Med. 2023 Nov 21. doi: 10.1111/hiv.13582.
PubMed Abstract available

BOTTANELLI M, Galli L, Guffanti M, Castagna A, et al
Are glucagon-like peptide 1 receptor agonists effective in decreasing body weight and body mass index in people living with diabetes and HIV?
HIV Med. 2023 Nov 21. doi: 10.1111/hiv.13587.
PubMed

HAN WM, Hiransuthikul A, Holroyd KB, Apornpong T, et al
Impact of steatotic liver disease and non-alcoholic steatohepatitis on cognitive impairment in people living with HIV: A cross-sectional study.
HIV Med. 2023 Nov 17. doi: 10.1111/hiv.13579.
PubMed Abstract available

CELIK D, van Bremen K, Breitschwerdt S, Elamouri F, et al
Hepatitis delta in HIV/hepatitis B coinfection: A call for action.
HIV Med. 2023 Nov 15. doi: 10.1111/hiv.13581.
PubMed

MILANI A, Akbari E, Pordanjani PM, Jamshidi F, et al
Immunostimulatory effects of Hsp70 fragments and Hsp27 in design of novel HIV-1 vaccine formulations.
HIV Med. 2023 Nov 7. doi: 10.1111/hiv.13576.
PubMed Abstract available

VAN HALSEMA CL, Eades CP, Johnston VJ, Miller RF, et al
British HIV Association guidelines on the management of opportunistic infection in people living with HIV: The clinical investigation and management of pyrexia of unknown origin 2023.
HIV Med. 2023;24 Suppl 4:3-18.
PubMed

October 2023

BOUCOIRAN I, Cote HCF, Jodoin C, Elwood C, et al
Variations in CD4 counts during pregnancy in women living with HIV.
HIV Med. 2023 Oct 25. doi: 10.1111/hiv.13569.
PubMed Abstract available

KISITU G, Shabanova V, Naiga F, Nakagwa M, et al
High prevalence of low high-density lipoprotein cholesterol and insulin resistance among children and adolescents living with HIV in Uganda: harbinger for metabolic syndrome?
HIV Med. 2023 Oct 25. doi: 10.1111/hiv.13570.
PubMed Abstract available

WATERS L, Hassan Wada Y, Barber TJ
International AIDS society conference 2023 summary.
HIV Med. 2023 Oct 23. doi: 10.1111/hiv.13563.
PubMed Abstract available

NANYEENYA N, Nakanjako D, Makumbi F, Nakigozi G, et al
Effectiveness of intensive adherence counselling in achieving an undetectable viral load among people on antiretroviral therapy with low-level viraemia in Uganda.
HIV Med. 2023 Oct 18. doi: 10.1111/hiv.13568.
PubMed Abstract available

AMBROSIONI J, Levi L, Alagaratnam J, Van Bremen K, et al
Major revision version 12.0 of the European AIDS Clinical Society guidelines 2023.
HIV Med. 2023 Oct 18. doi: 10.1111/hiv.13542.
PubMed Abstract available

DIRAJLAL-FARGO S, Jacobson DL, Yu W, Mirza A, et al
Longitudinal changes in body fat and metabolic complications in young people with perinatally acquired HIV.
HIV Med. 2023 Oct 16. doi: 10.1111/hiv.13566.
PubMed Abstract available

NDEGE R
Sero-negative HIV, a need for presumptive HIV diagnosis in adults in developing countries.
HIV Med. 2023 Oct 12. doi: 10.1111/hiv.13564.
PubMed

PAYRA S, Manjhi PK, Singh S, Kumar R, et al
HIV cure: Are we going to make history?
HIV Med. 2023 Oct 11. doi: 10.1111/hiv.13557.
PubMed Abstract available

GACIC N, Tulloch K, Money D, Tkachuk S, et al
Daily ritonavir-boosted darunavir for viral suppression in pregnancy (DRV-P).
HIV Med. 2023 Oct 10. doi: 10.1111/hiv.13546.
PubMed Abstract available

BEGRE L, Boyd A, Salazar-Vizcaya L, Suter-Riniker F, et al
Long-term quantitative hepatitis B surface antigen (HBsAg) trajectories in persons with and without HBsAg loss on tenofovir-containing antiretroviral therapy.
HIV Med. 2023 Oct 10. doi: 10.1111/hiv.13561.
PubMed Abstract available

FRANGE P, Veber F, Burgard M, Blanche S, et al
Bictegravir/emtricitabine/tenofovir alafenamide in paediatrics: Real-life experience from a French cohort (2019-2023).
HIV Med. 2023 Oct 8. doi: 10.1111/hiv.13562.
PubMed Abstract available

FLYGEL TT, Hameiri-Bowen D, Simms V, Rowland-Jones S, et al
Exhaled nitric oxide is associated with inflammatory biomarkers and risk of acute respiratory exacerbations in children with HIV-associated chronic lung disease.
HIV Med. 2023 Oct 7. doi: 10.1111/hiv.13565.
PubMed Abstract available

KOKORELIAS KM, Grosse A, Zhabokritsky A, Walmsley SL, et al
Exploring implementation considerations for geriatric-HIV clinics: A secondary analysis from a scoping review on HIV models of geriatric care.
HIV Med. 2023 Oct 4. doi: 10.1111/hiv.13549.
PubMed Abstract available

GOODEN TE, Nirantharakumar K, Thomas GN
Author reply: Letter to the editor on "A matched cohort study investigating premature, accentuated, and accelerated aging in people living with HIV".
HIV Med. 2023 Oct 4. doi: 10.1111/hiv.13560.
PubMed

CHADWICK D, Hill-Tout R
HIV medicine editorial: Opt-out HIV testing in the UK: Approaching the endgame?
HIV Med. 2023 Oct 2. doi: 10.1111/hiv.13555.
PubMed

KRINGS A, Schmidt D, Kollan C, Meixenberger K, et al
Increasing hepatitis B vaccination coverage and decreasing hepatitis B co-infection prevalence among people with HIV-1 in Germany, 1996-2019. Results from a cohort study primarily in men who have sex with men.
HIV Med. 2023 Oct 2. doi: 10.1111/hiv.13554.
PubMed Abstract available

GIGUERE K, Chartrand-Lefebvre C, Baril JG, Conway B, et al
Baseline characteristics of a prospective cohort study of aging and cardiovascular diseases among people living with HIV.
HIV Med. 2023 Oct 1. doi: 10.1111/hiv.13550.
PubMed Abstract available

September 2023

SUDOVEC-SOMOGYI JV, Krakauer F, Ferreira AA, Stabellini N, et al
Heterogeneities of the impact of public health policies on HIV/AIDS indicators in Brazil according to sociodemographic factors: A real-life study.
HIV Med. 2023 Sep 30. doi: 10.1111/hiv.13553.
PubMed Abstract available

GRAHAM EE, Michala L, Hatchfeld A, Moseholm E, et al
Collection of menopause data in studies of women living with HIV: A systematic literature review.
HIV Med. 2023 Sep 30. doi: 10.1111/hiv.13552.
PubMed Abstract available

COZZI-LEPRI A, Dunn D, Tostevin A, Marvig RL, et al
Rate of response to initial antiretroviral therapy according to level of pre-existing HIV-1 drug resistance detected by next-generation sequencing in the strategic timing of antiretroviral treatment (START) study.
HIV Med. 2023 Sep 29. doi: 10.1111/hiv.13556.
PubMed Abstract available

RABEN D, Kahama CB, Combs L, Stengaard A, et al
The use and impact of European Testing Week regional awareness campaigns to increase HIV and viral hepatitis testing coverage.
HIV Med. 2023 Sep 29. doi: 10.1111/hiv.13544.
PubMed Abstract available

DAUBY N, Motet C, Libois A, Martin C, et al
The value of herpes zoster prevention in patients aging with HIV: A narrative review.
HIV Med. 2023 Sep 29. doi: 10.1111/hiv.13548.
PubMed Abstract available

HOVAGUIMIAN F, Kouyos RD, Kusejko K, Schmidt AJ, et al
Incidence of sexually transmitted infections and association with behavioural factors: Time-to-event analysis of a large pre-exposure prophylaxis (PrEP) cohort.
HIV Med. 2023 Sep 28. doi: 10.1111/hiv.13543.
PubMed Abstract available

WIECHMANN SL, Tejo AM, Inacio MVS, Mesas AE, et al
Frailty in people 50 years or older living with HIV: A sex perspective.
HIV Med. 2023 Sep 27. doi: 10.1111/hiv.13551.
PubMed Abstract available

HANNA DB, Patel VV
Public HIV stigma: Still common around the world.
HIV Med. 2023 Sep 25. doi: 10.1111/hiv.13547.
PubMed

LUI GC, Wong GL, Yang HC, Sheng WH, et al
Current practice and recommendations for management of hepatitis B virus in people living with HIV in Asia.
HIV Med. 2023 Sep 21. doi: 10.1111/hiv.13545.
PubMed Abstract available

SONDERGAARD MH, Thavarajah JJ, Churchill Henson H, Wejse CM, et al
SARS-CoV-2 vaccine immunogenicity for people living with HIV: A systematic review and meta-analysis.
HIV Med. 2023 Sep 21. doi: 10.1111/hiv.13537.
PubMed Abstract available

ELEN S, Bjorkman P, Zazzi M, Bohm M, et al
Low-level HIV viraemia during antiretroviral therapy: Longitudinal patterns and predictors of viral suppression.
HIV Med. 2023 Sep 18. doi: 10.1111/hiv.13541.
PubMed Abstract available

MENDEZ-LOPEZ A, White TM, Fuster-RuizdeApodaca MJ, Lazarus JV, et al
Prevalence and sociodemographic determinants of public stigma towards people with HIV and its impact on HIV testing uptake: A cross-sectional study in 64 low- and middle-income countries.
HIV Med. 2023 Sep 6. doi: 10.1111/hiv.13536.
PubMed Abstract available

ARENAS-PINTO A, Bakewell N, Milinkovic A, Williams I, et al
Hepatic steatosis in people older and younger than fifty who are living with HIV and HIV-negative controls: A cross-sectional study nested within the POPPY cohort.
HIV Med. 2023 Sep 5. doi: 10.1111/hiv.13540.
PubMed Abstract available

August 2023

GRABMEIER-PFISTERSHAMMER K, Skorepa C, Breuer M, Masood M, et al
No evidence of asymptomatic monkeypox infection in a highly sexually active MSM population in Austria.
HIV Med. 2023 Aug 31. doi: 10.1111/hiv.13535.
PubMed Abstract available

DITZENBERGER GL, Oliveira VHF, Jankowski CM, Erlandson KM, et al
The use of non-invasive imaging modalities for the assessment of skeletal muscle quantity and quality in people with HIV: A narrative review.
HIV Med. 2023 Aug 31. doi: 10.1111/hiv.13539.
PubMed Abstract available

DOCTOR J, Winston A, Vera JH, Post FA, et al
Anticholinergic medications associated with falls and frailty in people with HIV.
HIV Med. 2023 Aug 29. doi: 10.1111/hiv.13532.
PubMed Abstract available

MINERS A, Lampe FC, Cambiano V, Schwenk A, et al
Estimating the hospital costs of care for people living with HIV in England using routinely collected data.
HIV Med. 2023 Aug 28. doi: 10.1111/hiv.13529.
PubMed Abstract available

SHENGIR M, Lebouche B, Elgretli W, Saeed S, et al
Switch to a raltegravir-based antiretroviral regimen in people with HIV and non-alcoholic fatty liver disease: A randomized controlled trial.
HIV Med. 2023 Aug 28. doi: 10.1111/hiv.13531.
PubMed Abstract available

WATERS L, Childs K
Reaching zero: Retention in HIV care is critical.
HIV Med. 2023 Aug 24. doi: 10.1111/hiv.13538.
PubMed

HENTZIEN M, Frossard J, Kouyos R, Prendki V, et al
External validation of the Dat'AIDS score: A risk score for predicting 5-year overall mortality in people living with HIV aged 60 years or older.
HIV Med. 2023 Aug 24. doi: 10.1111/hiv.13534.
PubMed Abstract available

PREVEDEN A, Colovic P, Garipi E, Bogdan M, et al
Influence of physical activity on endothelial function in people living with HIV.
HIV Med. 2023 Aug 17. doi: 10.1111/hiv.13533.
PubMed Abstract available

WANG H, Guo C, Zhang X, Xu Y, et al
Prognostic factors for competing risk in patients with AIDS-related Kaposi's sarcoma: A SEER population-based study.
HIV Med. 2023 Aug 13. doi: 10.1111/hiv.13530.
PubMed Abstract available

July 2023

CHAN TY, Marta M, Rackstraw S
Relapse of neurosymptomatic cerebrospinal fluid HIV RNA escape.
HIV Med. 2023 Jul 24. doi: 10.1111/hiv.13527.
PubMed Abstract available

KLEEBAYOON A, Wiwanitkit V
Comment on "A plague passing over: clinical features of the 2022 mpox outbreak in patients of colour living with HIV".
HIV Med. 2023 Jul 23. doi: 10.1111/hiv.13528.
PubMed

REISERT H, Miner B, Farhadian S
Sleep deficiency among people living with human immunodeficiency virus: A growing challenge.
HIV Med. 2023 Jul 23. doi: 10.1111/hiv.13526.
PubMed Abstract available

DRAGO F, Soshnik-Schierling L, Cabling ML, Pattarabanjird T, et al
Characterizing blood pressure trajectories in people living with HIV following antiretroviral therapy: A systematic review.
HIV Med. 2023 Jul 20. doi: 10.1111/hiv.13524.
PubMed Abstract available

RANCAN I, Cassol C, Graziani L, Tilli M, et al
Trend over time of HIV-1 drug resistance to nonnucleoside reverse transcriptase inhibitors (NNRTIs) and their drivers: A cohort study from Antiviral Response Cohort Analysis (ARCA).
HIV Med. 2023 Jul 13. doi: 10.1111/hiv.13525.
PubMed Abstract available

AI W, Fan C, Marley G, Tan RKJ, et al
Disparities in healthcare access and utilization among people living with HIV in China: A scoping review and meta-analysis.
HIV Med. 2023 Jul 5. doi: 10.1111/hiv.13523.
PubMed Abstract available

June 2023

LAKE JE, Miao H, Bowman ER, Clark JL, et al
Gender-affirming hormone therapy decreases d-dimer but worsens insulin sensitivity in transgender women.
HIV Med. 2023 Jun 29. doi: 10.1111/hiv.13522.
PubMed Abstract available

ZINO L, Tack CJ, Richel O, Burger DM, et al
GLP-1 agonists for people living with HIV and obesity, is there a potential?
HIV Med. 2023 Jun 20. doi: 10.1111/hiv.13521.
PubMed Abstract available

MOMIN ZK, Lee A, Vandergriff TW, Bowling JE, et al
A plague passing over: Clinical features of the 2022 mpox outbreak in patients of color living with HIV.
HIV Med. 2023 Jun 19. doi: 10.1111/hiv.13517.
PubMed Abstract available

HATTENHAUER ST, Mispelbaum R, Hentrich M, Boesecke C, et al
Enabling CAR T-cell therapies for HIV-positive lymphoma patients - A call for action.
HIV Med. 2023 Jun 15. doi: 10.1111/hiv.13514.
PubMed Abstract available

DEKOVEN S, Naccarato M, Brumme CJ, Tan DHS, et al
Treatment-emergent reverse transcriptase resistance during antiretroviral therapy with bictegravir, tenofovir alafenamide, and emtricitabine: A case series.
HIV Med. 2023 Jun 14. doi: 10.1111/hiv.13520.
PubMed Abstract available

BURGER D, Oosterhof P, Grintjes K, Marneef-Pietersma M, et al
Potential drug-drug interactions in males living with HIV who use drugs to treat lower urinary tract symptoms.
HIV Med. 2023 Jun 8. doi: 10.1111/hiv.13519.
PubMed Abstract available

VISCO COMANDINI U, De Santis E, De Maria F, Lionetti R, et al
"Real world" efficacy of bulevirtide in HBV/HDV-related cirrhosis including people living with HIV: Results from the compassionate use programme at INMI Spallanzani in Rome, Italy.
HIV Med. 2023 Jun 7. doi: 10.1111/hiv.13518.
PubMed Abstract available

MOLLER IK, Gisslen M, Wagner P, Sparen P, et al
COVID-19 hospitalization outcomes in adults by HIV status; a nation-wide register-based study.
HIV Med. 2023 Jun 7. doi: 10.1111/hiv.13515.
PubMed Abstract available

VASSALLO M, Fabre R, Bolla G, Manni S, et al
Prevalence of osteoporosis in people living with HIV and risk factors associated in the cART era.
HIV Med. 2023 Jun 2. doi: 10.1111/hiv.13516.
PubMed

May 2023

ROMO ML, Esber AL, Owuoth J, Maswai J, et al
Impact of weight gain with dolutegravir on antiretroviral adherence and viral suppression in four African countries.
HIV Med. 2023 May 25. doi: 10.1111/hiv.13501.
PubMed Abstract available

PALMIER E, De Miguel R, Montejano R, Busca C, et al
Three-year efficacy of switching to dolutegravir plus lamivudine: A real-world study.
HIV Med. 2023 May 16. doi: 10.1111/hiv.13500.
PubMed Abstract available

HAN WM, Apornpong T, Chattranukulchai P, Siwamogsatham S, et al
Metabolic-Associated Fatty Liver Disease (MAFLD) is associated with immune activation, increased epicardial fat volume, and steatohepatitis among people with HIV in a Thai cohort.
HIV Med. 2023 May 11. doi: 10.1111/hiv.13499.
PubMed Abstract available

DA SILVEIRA GOUVEA MIF, de Lourdes Benamor Teixeira M, Fuller T, Sodre MCMP, et al
Resistance rates among antiretroviral regimens in pregnant people living with HIV.
HIV Med. 2023 May 4. doi: 10.1111/hiv.13498.
PubMed Abstract available

MOREL Z, Aguilar G, Samudio T, Lopez G, et al
Intergenerational sex and early sexual debut are associated with HIV infection among transgender women in Paraguay.
HIV Med. 2023 May 1. doi: 10.1111/hiv.13496.
PubMed Abstract available

April 2023

SURIAL B, Wandeler G
Tenofovir alafenamide and weight: What do we still need to know to inform clinical decisions?
HIV Med. 2023 Apr 24. doi: 10.1111/hiv.13497.
PubMed

ISITT C, Bartolf A, Andrews N, Athaide S, et al
The propositive study: Immunogenicity and safety of a four-component recombinant protein-based vaccine against MenB and a quadrivalent conjugate MenACWY vaccine in people living with HIV.
HIV Med. 2023 Apr 23. doi: 10.1111/hiv.13495.
PubMed Abstract available

FITZGERALD N, Coltart H, Dominguez L, Flanagan K, et al
PrEP for women in Europe: a systematic literature review.
HIV Med. 2023 Apr 23. doi: 10.1111/hiv.13458.
PubMed Abstract available

COUKAN F, Murray KK, Papageorgiou V, Lound A, et al
Barriers and facilitators to HIV Pre-Exposure Prophylaxis (PrEP) in Specialist Sexual Health Services in the United Kingdom: A systematic review using the PrEP Care Continuum.
HIV Med. 2023 Apr 19. doi: 10.1111/hiv.13492.
PubMed Abstract available

GILLES C, Konopnicki D, Rozenberg S
The recent natural history of human papillomavirus cervical infection in women living with HIV: A scoping review of meta-analyses and systematic reviews and the construction of a hypothetical model.
HIV Med. 2023 Apr 16. doi: 10.1111/hiv.13490.
PubMed Abstract available

PROTIERE C, Sagaon-Teyssier L, Donadille C, Sow A, et al
Perception of PrEP-related stigma in PrEP users: Results from the ANRS-PREVENIR cohort.
HIV Med. 2023 Apr 12. doi: 10.1111/hiv.13491.
PubMed Abstract available

LEHMAN A, Ellis J, Nalintya E, Bahr NC, et al
Advanced HIV disease: A review of diagnostic and prophylactic strategies.
HIV Med. 2023 Apr 11. doi: 10.1111/hiv.13487.
PubMed Abstract available

NASREDDINE R, Florence E, Yombi JC, Henrard S, et al
Efficacy, durability, and tolerability of bictegravir/emtricitabine/tenofovir alafenamide for the treatment of HIV in a real-world setting in Belgium.
HIV Med. 2023 Apr 10. doi: 10.1111/hiv.13493.
PubMed Abstract available

MORRIS R, Alford K, Vera JH
How are HIV services in the UK currently identifying and managing patients with cognitive impairment? Results of a national survey.
HIV Med. 2023 Apr 5. doi: 10.1111/hiv.13494.
PubMed Abstract available

PALACIOS R, Gomez-Ayerbe C, Casado JL, Tejerina F, et al
Efficacy and safety of dolutegravir/rilpivirine in real-world clinical practice. GeSIDA study 1119.
HIV Med. 2023 Apr 4. doi: 10.1111/hiv.13489.
PubMed Abstract available

HOCQUELOUX L, Menard A, Arvieux C, Joly V, et al
Weight gain following the single substitution of tenofovir disoproxil fumarate by tenofovir alafenamide in HIV-infected people from the French Dat'AIDS cohort: A propensity score-matched analysis.
HIV Med. 2023 Apr 4. doi: 10.1111/hiv.13488.
PubMed Abstract available

March 2023

ABD-ELMONIEM KZ, Yeramosu T, Purdy JB, Ouwerkerk R, et al
The role of HIV as a risk modifier for coronary endothelial function in young adults.
HIV Med. 2023 Mar 30. doi: 10.1111/hiv.13484.
PubMed Abstract available

PALACIO-VIEIRA J, Moreno-Fornes S, Diaz Y, Aceiton J, et al
Who is lost to follow-up in HIV care? Assessment of care retention over time and the impact of COVID-19. Longitudinal analysis of the PISCIS cohort.
HIV Med. 2023 Mar 29. doi: 10.1111/hiv.13486.
PubMed Abstract available

PANTKE A, Kollan C, Gunsenheimer-Bartmeyer B, Jensen BO, et al
AIDS in the era of antiretroviral therapy: Changes in incidence rates and predictors of AIDS among people living with HIV under clinical care in Germany, a cohort study 1999-2018.
HIV Med. 2023 Mar 22. doi: 10.1111/hiv.13482.
PubMed Abstract available

ABIMIKU A, Ramadhani HO, Moloney M, Stafford KA, et al
Factors associated with viral suppression among adults living with HIV on antiretroviral therapy in Nigeria: Analysis of a population-based survey, 2018.
HIV Med. 2023 Mar 21. doi: 10.1111/hiv.13485.
PubMed Abstract available

CASTEN M, Herbert S, Smith DJ, Petoumenos K, et al
What are the predictors of change in multimorbidity among people with HIV? A longitudinal observational cohort study.
HIV Med. 2023 Mar 16. doi: 10.1111/hiv.13483.
PubMed Abstract available

ALAGARATNAM J, Sabin CA, Garvey LJ, Ramzan F, et al
Evaluating virological outcomes in people with HIV on stable antiretroviral therapy with reduced frequency of HIV viral load monitoring during the COVID-19 pandemic.
HIV Med. 2023 Mar 9. doi: 10.1111/hiv.13474.
PubMed Abstract available

HENDERSON M, Pepper N, Bawa M, Muir D, et al
Cerebrospinal fluid virology in people with HIV.
HIV Med. 2023 Mar 9. doi: 10.1111/hiv.13471.
PubMed Abstract available

DAMAS J, Darling KEA, Bidlingmeyer P, Nadin-Deblue I, et al
One for all, all for one: neuro-HIV multidisciplinary platform for the assessment and management of neurocognitive complaints in people living with HIV.
HIV Med. 2023 Mar 8. doi: 10.1111/hiv.13472.
PubMed Abstract available

MALIN JJ, Suarez I, Biehl LM, Schommers P, et al
Immune response to mRNA-based COVID-19 booster vaccination in people living with HIV.
HIV Med. 2023 Mar 8. doi: 10.1111/hiv.13481.
PubMed Abstract available

MARTIN C, Bottieau E, Delforge M, Dauby N, et al
Do people living with HIV travel safely? Assessment of travel patterns and advice-seeking behaviour in a cohort of people living with HIV in Belgium.
HIV Med. 2023 Mar 8. doi: 10.1111/hiv.13470.
PubMed Abstract available

LAZARUS JV, Wohl DA, Cascio M, Guaraldi G, et al
Long-term success for people living with HIV: A framework to guide practice.
HIV Med. 2023;24 Suppl 2:8-19.
PubMed Abstract available

FUSTER-RUIZDEAPODACA MJ, Wohl DA, Cascio M, Guaraldi G, et al
Why we need to re-define long-term success for people living with HIV.
HIV Med. 2023;24 Suppl 2:3-7.
PubMed Abstract available

DUNN K, Bushen J, Luo D, Cai J, et al
Darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-naive (AMBER) and virologically suppressed (EMERALD) participants with neurological and/or psychiatric comorbidities: Week 96 subgroup analysis.
HIV Med. 2023;24:279-289.
PubMed Abstract available

AVIHINGSANON A, Chetchotisakd P, Kiertiburanakul S, Ratanasuwan W, et al
Efficacy and safety of switching to bictegravir, emtricitabine, and tenofovir alafenamide in virologically suppressed Asian adults living with HIV: A pooled analysis from three international phase III randomized trials.
HIV Med. 2023;24:290-300.
PubMed Abstract available

DOAK 2023 / German-Austrian AIDS Conference, World Conference Center Bonn, 23-25 March 2023.
HIV Med. 2023;24 Suppl 1:3-97.
PubMed

February 2023

DRUMRIGHT LN, Nance RM, Ruderman SA, Ma J, et al
Associations between alcohol and cigarette use and type 1 and 2 myocardial infarction among people with HIV.
HIV Med. 2023 Feb 28. doi: 10.1111/hiv.13466.
PubMed Abstract available

DENG X, Li L, Cai X, Lin Y, et al
Evaluation of the performance of a novel HIV-1 viral load assay for HIV quantification in China.
HIV Med. 2023 Feb 26. doi: 10.1111/hiv.13473.
PubMed Abstract available

RUIZ-ALGUERO M, Izquierdo R, Suarez-Garcia I, Moreno C, et al
Unplanned pregnancies and social and partner support during pregnancy in Spanish women living with HIV.
HIV Med. 2023 Feb 21. doi: 10.1111/hiv.13469.
PubMed Abstract available

MOUNZER K, Brunet L, Fusco JS, McNicholl IR, et al
Immune response to ART initiation in advanced HIV infection.
HIV Med. 2023 Feb 15. doi: 10.1111/hiv.13467.
PubMed Abstract available

PENA-COTUI N
Letter to the editor on "a matched cohort study investigating premature, accentuated, and accelerated aging in people living with HIV".
HIV Med. 2023 Feb 13. doi: 10.1111/hiv.13468.
PubMed

PEREZ-BARRAGAN E, Perez-Cavazos S, Rodriguez-Aldama JC, Cruz-Flores RA, et al
Mimicking measles and syphilis: Mpox in PLHIV.
HIV Med. 2023 Feb 13. doi: 10.1111/hiv.13462.
PubMed

January 2023

KA'E AC, Fokam J, Togna Pabo WLR, Nanfack A, et al
Evaluation of archived drug resistance mutations in HIV-1 DNA among vertically infected adolescents under antiretroviral treatment in Cameroon: Findings during the COVID-19 pandemic.
HIV Med. 2023 Jan 30. doi: 10.1111/hiv.13459.
PubMed Abstract available

GETANEH Y, Khairunisa S, Husada D, Kuntaman K, et al
Burden of HIV, HBV and syphilis among children in urban Ethiopia: Community-based cross-sectional study.
HIV Med. 2023 Jan 29. doi: 10.1111/hiv.13457.
PubMed Abstract available

FATKENHEUER G, Lehmann C
Monkeypox: Lessons from a large cohort.
HIV Med. 2023 Jan 17. doi: 10.1111/hiv.13395.
PubMed

GALICIA M
Editorial comment on: Amphetamine-related intoxications in people living with HIV: An observational study in an emergency department in Barcelona (Spain) from 2018 to 2020.
HIV Med. 2023 Jan 17. doi: 10.1111/hiv.13387.
PubMed

CAMPBELL LR, Silverstein A, Peckham-Gregory E, Kamiyango W, et al
Divergent clinical presentations and outcomes among children and adolescents with Kaposi sarcoma in Malawi and Tanzania.
HIV Med. 2023 Jan 10. doi: 10.1111/hiv.13455.
PubMed Abstract available

KING EM, Swann SA, Prior JC, Berger C, et al
Vitamin D intakes among women living with and without HIV in Canada.
HIV Med. 2023 Jan 4. doi: 10.1111/hiv.13454.
PubMed Abstract available

MAZZITELLI M, Foca' E, Prosperi M, Cauda R, et al
Liver fibrosis may lower PSA levels: A further reason to be wary in prostate cancer screening in men with HIV?
HIV Med. 2023 Jan 2. doi: 10.1111/hiv.13456.
PubMed

WATERS L, Hodson M, Josh J
Language matters: The importance of person-first language and an introduction to the People First Charter.
HIV Med. 2023;24:3-5.
PubMed

December 2022

REYES N, Benites C, Garcia-Fernandez L, Calderon M, et al
HIV treatment cascade in regions of Peru with the highest HIV prevalence.
HIV Med. 2022 Dec 27. doi: 10.1111/hiv.13452.
PubMed Abstract available

RAHMAN F, Brates I, Aweeka F, Bosch RJ, et al
Evaluating the effect of atorvastatin exposure and vitamin D levels on lipid outcomes in people with HIV-1 with suppressed HIV-1 RNA and LDL cholesterol <130 mg/dL.
HIV Med. 2022 Dec 22. doi: 10.1111/hiv.13453.
PubMed Abstract available

PULA J, Kowalska J, Paciorek M, Bednarska A, et al
Is the definition of late diagnosis correct?
HIV Med. 2022 Dec 7. doi: 10.1111/hiv.13450.
PubMed Abstract available

LIEGEON G, Ghosn J
Long-acting injectable cabotegravir for PrEP: A game-changer in HIV prevention?
HIV Med. 2022 Dec 5. doi: 10.1111/hiv.13451.
PubMed Abstract available

HOMEROVA I, Patel A, Macallan DC
'We want it all': ART preferences assessed by Desirability of Outcome Ranking.
HIV Med. 2022 Dec 1. doi: 10.1111/hiv.13447.
PubMed Abstract available

PARCZEWSKI M, Rockstroh JK
Late HIV diagnosis: Where we stand and the way forward.
HIV Med. 2022;23:1115-1117.
PubMed

BHIVA guidelines on antiretroviral treatment for adults living with HIV-1 2022.
HIV Med. 2022;23 Suppl 5:3-115.
PubMed

November 2022

NAHIRNEY M, Grist J, Namasopo S, Brophy J, et al
Evolution of prevention of vertical HIV transmission in Uganda: 2008-2017.
HIV Med. 2022 Nov 30. doi: 10.1111/hiv.13449.
PubMed Abstract available

MAGGI P, Ricci ED, Muccini C, Galli L, et al
Subclinical atherosclerosis as detected by carotid ultrasound and associations with cardiac and HIV-specific risk factors; the Archi-Prevaleat project.
HIV Med. 2022 Nov 30. doi: 10.1111/hiv.13448.
PubMed Abstract available

LAZARUS JV, Van Hout MC, Fuster-Ruizdeapodaca MJ, Brown G, et al
A call for health systems to monitor the health-related quality of life of people living with HIV.
HIV Med. 2022 Nov 23. doi: 10.1111/hiv.13427.
PubMed Abstract available

CORRIGENDUM.
HIV Med. 2022 Nov 22. doi: 10.1111/hiv.13434.
PubMed

PATEL P, Ford SL, Baker M, Meyer C, et al
Pregnancy outcomes and pharmacokinetics in pregnant women living with HIV exposed to long-acting cabotegravir and rilpivirine in clinical trials.
HIV Med. 2022 Nov 21. doi: 10.1111/hiv.13439.
PubMed Abstract available

BAKEWELL N, Kanitkar T, Dissanayake O, Symonds M, et al
Estimating the risk of mortality attributable to recent late HIV diagnosis following admission to the intensive care unit: A single-centre observational cohort study.
HIV Med. 2022 Nov 20. doi: 10.1111/hiv.13436.
PubMed Abstract available

COLLINS S, Namiba A, Sparrowhawk A, Strachan S, et al
Late diagnosis of HIV in 2022: Why so little change?
HIV Med. 2022 Nov 17. doi: 10.1111/hiv.13444.
PubMed Abstract available

BENDALA-ESTRADA AD, Diaz-Almiron M, Busca C, Mican R, et al
Change in metabolic parameters after switching from triple regimens with tenofovir alafenamide to dolutegravir-based dual therapy. Bi-lipid study.
HIV Med. 2022 Nov 16. doi: 10.1111/hiv.13432.
PubMed Abstract available

PAPARINI S, Whitacre R, Smuk M, Thornhill J, et al
Public understanding and awareness of and response to monkeypox virus outbreak: A cross-sectional survey of the most affected communities in the United Kingdom during the 2022 public health emergency.
HIV Med. 2022 Nov 16. doi: 10.1111/hiv.13430.
PubMed Abstract available

MARCHANT R, Patterson A, Dragovic B, Kelly B, et al
High-level compliance to opt-out HIV testing in the emergency department (ED) of a large teaching hospital using the biochemistry sample as the sample type for HIV screening.
HIV Med. 2022 Nov 14. doi: 10.1111/hiv.13441.
PubMed Abstract available

NWOKOLO N, Post E, Mageau AS, Shah R, et al
Fostemsavir and ethinyl estradiol drug interaction: Clinical recommendations for co-administration.
HIV Med. 2022 Nov 13. doi: 10.1111/hiv.13442.
PubMed Abstract available

SUCHACZ MM, Krankowska D, Cybula A, Kamerys J, et al
Delayed HIV diagnosis during the COVID-19 pandemic in Poland: A call for targeted HIV testing for those under suspicion of SARS-CoV-2.
HIV Med. 2022 Nov 13. doi: 10.1111/hiv.13437.
PubMed Abstract available

SEVERIN S, Delforge M, De Wit S
Epidemiology, comorbidities at diagnosis and outcomes associated with HIV late diagnosis from 2010 to 2019 in a Belgian reference centre: A retrospective study.
HIV Med. 2022 Nov 10. doi: 10.1111/hiv.13440.
PubMed Abstract available

OWEN R, Maan I, Waters L
Key data from AIDS 2022.
HIV Med. 2022 Nov 8. doi: 10.1111/hiv.13438.
PubMed Abstract available

CROXFORD S, Stengaard AR, Brannstrom J, Combs L, et al
Late diagnosis of HIV: An updated consensus definition.
HIV Med. 2022 Nov 8. doi: 10.1111/hiv.13425.
PubMed Abstract available

HU FH, Zhao DY, Fu XL, Zhang WQ, et al
Gender differences in suicidal ideation, suicide attempts, and suicide death among people living with HIV: A systematic review and meta-analysis.
HIV Med. 2022 Nov 8. doi: 10.1111/hiv.13435.
PubMed Abstract available

MWEBAZA J, Meya D, Musiime V, Birungi C, et al
Prevalence of neuropsychiatric adverse events and associated factors among adult patients on dolutegravir attending Mulago ISS clinic.
HIV Med. 2022 Nov 6. doi: 10.1111/hiv.13428.
PubMed Abstract available

VAZ-PINTO I, Gorgulho A, Esteves C, Guimaraes M, et al
Increasing HIV early diagnosis by implementing an automated screening strategy in emergency departments.
HIV Med. 2022 Nov 1. doi: 10.1111/hiv.13431.
PubMed Abstract available

October 2022

LI J, Chen X, Lin H, Yuan S, et al
Associations between HIV infection and frailty status and its individual components: Are frailty components disproportionally affected?
HIV Med. 2022 Oct 26. doi: 10.1111/hiv.13429.
PubMed Abstract available

EHLERS LH, Axelsen F, Bojer Rasmussen T, Dollerup J, et al
Cost of non-communicable diseases in people living with HIV in the Central Denmark Region.
HIV Med. 2022 Oct 23. doi: 10.1111/hiv.13414.
PubMed Abstract available

VAN BREMEN K, Monin M, Schlabe S, Bischoff J, et al
Impact of COVID-19 on HIV late diagnosis in a specialized German centre.
HIV Med. 2022 Oct 20. doi: 10.1111/hiv.13426.
PubMed Abstract available

KOSTAKI EG, Limnaios S, Adamis G, Xylomenos G, et al
Estimation of the determinants for HIV late presentation using the traditional definition and molecular clock-inferred dates: Evidence that older age, heterosexual risk group and more recent diagnosis are prognostic factors.
HIV Med. 2022 Oct 18. doi: 10.1111/hiv.13415.
PubMed Abstract available

ST CLAIR-SULLIVAN N, Simmons K, Harding-Swale R, Levett T, et al
Frailty and frailty screening: A qualitative study to elicit perspectives of people living with HIV and their healthcare professionals.
HIV Med. 2022 Oct 13. doi: 10.1111/hiv.13419.
PubMed Abstract available

DE LA COURT F, Boyd A, Coyer L, van den Elshout M, et al
The impact of COVID-19-related restrictions in 2020 on sexual healthcare use, pre-exposure prophylaxis use, and sexually transmitted infection incidence among men who have sex with men in Amsterdam, the Netherlands.
HIV Med. 2022 Oct 13. doi: 10.1111/hiv.13374.
PubMed Abstract available

PAPADOPOULOS A, Thomas K, Protopapas K, Antonyak S, et al
HIV treatment strategies across Central, Eastern and Southeastern Europe: New times, old problems.
HIV Med. 2022 Oct 4. doi: 10.1111/hiv.13416.
PubMed Abstract available

CECHIN L, Norcross C, Oliveira A, Hopkins D, et al
Obesity and diabetes in people of African ancestry with HIV.
HIV Med. 2022 Oct 4. doi: 10.1111/hiv.13413.
PubMed Abstract available

IN BRIEF: BHIVA guidelines on antiretroviral treatment for adults living with HIV-1 2022.
HIV Med. 2022;23 Suppl 3:3-14.
PubMed

HUNG CC, Phanuphak N, Wong CS, Olszyna DP, et al
Same-day and rapid initiation of antiretroviral therapy in people living with HIV in Asia. How far have we come?
HIV Med. 2022;23 Suppl 4:3-14.
PubMed Abstract available

September 2022

EPALZA C, Dominguez-Rodriguez S, Cervantes E, Jimenez de Ory S, et al
Factors associated with late presentation for HIV care in adolescents in Spain.
HIV Med. 2022 Sep 30. doi: 10.1111/hiv.13407.
PubMed Abstract available

RAYA RP, Curtis H, Kulasegaram R, Cooke GS, et al
The British HIV Association national clinical audit 2021: Management of HIV and hepatitis C coinfection.
HIV Med. 2022 Sep 29. doi: 10.1111/hiv.13417.
PubMed Abstract available

FERREIRA AACM, Pinho RGG, de Aquino LM, de Barros Perini F, et al
Disparities in HIV continuum of care in the paediatric population: A real-life study in Brazil.
HIV Med. 2022 Sep 26. doi: 10.1111/hiv.13405.
PubMed Abstract available

LEVETT TJ, Vera JH, Jones CI, Bremner S, et al
A cross-sectional assessment of frailty, falls and perceptions of ageing in people living with HIV using an mHealth platform.
HIV Med. 2022 Sep 25. doi: 10.1111/hiv.13409.
PubMed Abstract available

LE LT, Price RW, Gisslen M, Zetterberg H, et al
Correlation between CD4/CD8 ratio and neurocognitive performance during early HIV infection.
HIV Med. 2022 Sep 22. doi: 10.1111/hiv.13411.
PubMed Abstract available

FITZPATRICK C, Richardson D, Sherriff N, Whetham J, et al
Pilot evaluation of PrEP EmERGE - A novel digital health innovation designed to support sexual health clinics and HIV-PrEP users.
HIV Med. 2022 Sep 22. doi: 10.1111/hiv.13406.
PubMed Abstract available

HIKASA S, Shimabukuro S, Hideta K, Higasa S, et al
Comparison between the impact of tenofovir alafenamide and that of abacavir on rapid kidney function decline: A retrospective observational study.
HIV Med. 2022 Sep 20. doi: 10.1111/hiv.13408.
PubMed Abstract available

MCGETTIGAN P, Morales DR, Moreno-Martos D, Matin N, et al
Changing co-morbidity and increasing deprivation among people living with HIV: UK population-based cross-sectional study.
HIV Med. 2022 Sep 19. doi: 10.1111/hiv.13389.
PubMed Abstract available

SHAPIRO AE, Tenforde MW, Chiller TM, Ford N, et al
An updated systematic review of HIV-associated cryptococcal meningitis treatment strategies.
HIV Med. 2022 Sep 19. doi: 10.1111/hiv.13412.
PubMed Abstract available

ZHANG Q, Jiao YM, Li G, Zhang LX, et al
Serum globulin levels are associated with HIV reservoir size and immune restoration during long-term ART.
HIV Med. 2022 Sep 13. doi: 10.1111/hiv.13393.
PubMed Abstract available

ABIOYE AI, Sudfeld CR, Hughes MD, Aboud S, et al
Iron status among HIV-infected adults during the first year of antiretroviral therapy in Tanzania.
HIV Med. 2022 Sep 8. doi: 10.1111/hiv.13396.
PubMed Abstract available

KIRWAN PD, Croxford S, Aghaizu A, Murphy G, et al
Re-assessing the late HIV diagnosis surveillance definition in the era of increased and frequent testing.
HIV Med. 2022 Sep 7. doi: 10.1111/hiv.13394.
PubMed Abstract available

FULLER T, Fragoso da Silveira Gouvea MI, Benamor Teixeira ML, Ferreira Medeiros A, et al
Real-world experience with weight gain among pregnant women living with HIV who are using integrase inhibitors.
HIV Med. 2022 Sep 5. doi: 10.1111/hiv.13388.
PubMed Abstract available

HOFFMANN C, Jessen H, Wyen C, Grunwald S, et al
Clinical characteristics of monkeypox virus infections among men with and without HIV: A large outbreak cohort in Germany.
HIV Med. 2022 Sep 4. doi: 10.1111/hiv.13378.
PubMed Abstract available

August 2022

KABLAWI D, Alhinai A, Wong P, Deschenes M, et al
Splenomegaly is a marker of advanced chronic liver disease and portal hypertension in HIV infection.
HIV Med. 2022 Aug 30. doi: 10.1111/hiv.13390.
PubMed Abstract available

AKSAK-WAS BJ, Kowalska JD, Zabek P, Serwin K, et al
Immune restoration affects 10-year survival in people living with HIV/AIDS.
HIV Med. 2022 Aug 25. doi: 10.1111/hiv.13391.
PubMed Abstract available

BALUKU JB, Nabwana M, Mwanahamisi SB, Kansiime G, et al
Early culture conversion is a poor marker of treatment outcome among people with HIV and drug-resistant TB.
HIV Med. 2022 Aug 22. doi: 10.1111/hiv.13392.
PubMed Abstract available

OCEGUERA S, Tulloch K, Tkachuk S
Post-partum contraception in women living with HIV.
HIV Med. 2022 Aug 16. doi: 10.1111/hiv.13371.
PubMed Abstract available

SHAFRAN SD, Hughes CA
Bictegravir/emtricitabine/tenofovir alafenamide in patients with genotypic NRTI resistance.
HIV Med. 2022 Aug 16. doi: 10.1111/hiv.13376.
PubMed Abstract available

D'AMICO R, Cenoz Gomis S, Moodley R, Van Solingen-Ristea R, et al
Compassionate use of long-acting cabotegravir plus rilpivirine for people living with HIV-1 in need of parenteral antiretroviral therapy.
HIV Med. 2022 Aug 9. doi: 10.1111/hiv.13370.
PubMed Abstract available

PERELLO R, Losada A, Chen J, Supervia A, et al
Amphetamine-related intoxications in people living with HIV: An observational study in an emergency department in Barcelona (Spain) from 2018 to 2020.
HIV Med. 2022 Aug 9. doi: 10.1111/hiv.13365.
PubMed Abstract available

LIONS C, Laroche H, Mora M, Pialoux G, et al
Missed opportunities for HIV pre-exposure prophylaxis among people with recent HIV infection: The French ANRS 95041 OMaPrEP study.
HIV Med. 2022 Aug 9. doi: 10.1111/hiv.13367.
PubMed Abstract available

NASREDDINE R, Yombi JC, Darcis G, Florence E, et al
Efficacy, durability, and tolerability of dolutegravir/lamivudine and dolutegravir/rilpivirine for the treatment of HIV in a real-world setting in Belgium.
HIV Med. 2022 Aug 8. doi: 10.1111/hiv.13373.
PubMed Abstract available

NIKOLAICHUK M, Mocroft A, Wandeler G, Szlavik J, et al
Use of contraindicated antiretroviral drugs in people with HIV/HCV coinfections receiving HCV treatment with direct-acting antivirals-Results from the EuroSIDA study.
HIV Med. 2022 Aug 8. doi: 10.1111/hiv.13357.
PubMed Abstract available

GARCIA YD, Urena FA, Carrion-Nessi FS, Diaz SY, et al
HBV, HCV, or syphilis coinfection with HIV in pregnant women seen at the main hospital in the capital of Venezuela.
HIV Med. 2022 Aug 7. doi: 10.1111/hiv.13372.
PubMed

GOODEN TE, Wang J, Zemedikun DT, Taylor S, et al
A matched cohort study investigating premature, accentuated, and accelerated aging in people living with HIV.
HIV Med. 2022 Aug 7. doi: 10.1111/hiv.13375.
PubMed Abstract available

GARCIA JM, Dong Y, Richardson P, Kramer JR, et al
Effect of HIV and antiretroviral therapy use on body weight changes in a cohort of U.S. veterans living with and without HIV.
HIV Med. 2022 Aug 5. doi: 10.1111/hiv.13366.
PubMed Abstract available

KING EM, Swann SA, Murray MCM
Markers of ovarian reserve in women living with HIV: A systematic review.
HIV Med. 2022 Aug 2. doi: 10.1111/hiv.13364.
PubMed Abstract available

July 2022

SCHUETTFORT G, Groh A, Kann G, Haberl A, et al
Sexually transmitted diseases in people living with HIV after implementation of cost coverage of HIV pre-exposure prophylaxis by statutory health insurance in Germany.
HIV Med. 2022 Jul 20. doi: 10.1111/hiv.13353.
PubMed Abstract available

TSAKONA D, Kapetanakis A, Kyrou D, Vrontaras N, et al
Mapping frailty in people living with HIV: A nationwide study in Greece.
HIV Med. 2022 Jul 15. doi: 10.1111/hiv.13356.
PubMed Abstract available

RACCAGNI AR, Bruzzesi E, Calzavara D, Vinti P, et al
HIV-NAAT use for early detection of HIV infection among high-risk men who have sex with men in Italy.
HIV Med. 2022 Jul 15. doi: 10.1111/hiv.13363.
PubMed

GILL RC, Levett T, Youssef E
An audit of HIV testing practice in people aged 50 years and over presenting with a known clinical indicator condition in secondary care.
HIV Med. 2022 Jul 10. doi: 10.1111/hiv.13355.
PubMed Abstract available

EU B, Dawe J, Dunn M, Lee K, et al
Are there additional adverse effects of testosterone use among men living with HIV?-Data from the PUSH! study.
HIV Med. 2022 Jul 2. doi: 10.1111/hiv.13354.
PubMed

Erratum.
HIV Med. 2022;23:701.
PubMed

June 2022

LI M, Wang Q
Predicting the loss to follow-up (LTFU) of HIV/AIDS patients in China using a recency-frequency (RF) model.
HIV Med. 2022 Jun 27. doi: 10.1111/hiv.13324.
PubMed Abstract available

KHUON D, Rupasinghe D, Saphonn V, Kwong TS, et al
BMI as a predictor of high fasting blood glucose among people living with HIV in the Asia-Pacific region.
HIV Med. 2022 Jun 24. doi: 10.1111/hiv.13351.
PubMed Abstract available

BROWN JA, Nsakala BL, Mokhele K, Rakuoane I, et al
Dolutegravir in real life: Self-reported mental and physical health outcomes after transitioning from efavirenz- to dolutegravir-based antiretroviral therapy in a prospective cohort study in Lesotho.
HIV Med. 2022 Jun 22. doi: 10.1111/hiv.13352.
PubMed Abstract available

SIMMONS R, Plunkett J, Cieply L, Ijaz S, et al
Blood-borne virus testing in emergency departments - a systematic review of seroprevalence, feasibility, acceptability and linkage to care.
HIV Med. 2022 Jun 14. doi: 10.1111/hiv.13328.
PubMed Abstract available

CARVALHO S, Lee T, Tulloch KJ, Sauve LJ, et al
Prescribing patterns of antiretroviral treatments during pregnancy for women living with HIV in Canada 2004-2020: A surveillance study.
HIV Med. 2022 Jun 14. doi: 10.1111/hiv.13346.
PubMed Abstract available

SIDDIQI KA, Ostermann J, Zhang J, Khan MM, et al
Ageing with HIV in the United States: Changing trends in inpatient hospital stays and comorbidities, 2003-2015.
HIV Med. 2022 Jun 8. doi: 10.1111/hiv.13325.
PubMed Abstract available

SEXTON H, Kumarendran M, Brandon Z, Shi C, et al
Adverse perinatal outcomes associated with timing of initiation of antiretroviral therapy: Systematic review and meta-analysis.
HIV Med. 2022 Jun 6. doi: 10.1111/hiv.13326.
PubMed Abstract available

PULA J, Kowalska J, Paciorek M, Bednarska A, et al
Late diagnosis of HIV infection in Warsaw: Estimating the scale of the problem and demographic trends.
HIV Med. 2022 Jun 6. doi: 10.1111/hiv.13323.
PubMed Abstract available

May 2022

ANDERSON K, Pietersen E, Shepherd BE, Bian A, et al
High mortality among patients hospitalized for drug-resistant tuberculosis with acquired second-line drug resistance and high HIV prevalence.
HIV Med. 2022 May 24. doi: 10.1111/hiv.13318.
PubMed Abstract available

GIZAW A, King WC, Hinerman AS, Chung RT, et al
A prospective cohort study of renal function and bone turnover in adults with hepatitis B virus (HBV)-HIV co-infection with high prevalence of tenofovir-based antiretroviral therapy use.
HIV Med. 2022 May 16. doi: 10.1111/hiv.13322.
PubMed Abstract available

YU H, Yang Y, Cao D, Zhao Y, et al
Association of low-level viremia with mortality among people living with HIV on antiretroviral therapy in Dehong, Southwest China: A retrospective cohort study.
HIV Med. 2022 May 16. doi: 10.1111/hiv.13320.
PubMed Abstract available

MAGGIOLO F, Rizzardini G, Molina JM, Pulido F, et al
Bictegravir/emtricitabine/tenofovir alafenamide in older individuals with HIV: Results of a 96-week, phase 3b, open-label, switch trial in virologically suppressed people >/=65 years of age.
HIV Med. 2022 May 8. doi: 10.1111/hiv.13319.
PubMed Abstract available

TINGGAARD M, David KP, Gerstoft J, Hansen AE, et al
Potential drug-drug interactions between antiretroviral drugs and comedications, including dietary supplements, among people living with HIV: A clinical survey.
HIV Med. 2022 May 6. doi: 10.1111/hiv.13321.
PubMed Abstract available

GRIMSHAW C, Trayner KMA
Editorial on 'Epidemiology of HIV infection and associated behaviours among people who inject drugs in England, Wales, and Northern Ireland: nearly 40 years on'.
HIV Med. 2022 May 4. doi: 10.1111/hiv.13300.
PubMed

April 2022

BONJOCH A, Juega J, Echeverria P, Puig J, et al
Prevalence, progression, and management of advanced chronic kidney disease in a cohort of people living with HIV.
HIV Med. 2022 Apr 26. doi: 10.1111/hiv.13317.
PubMed Abstract available

HOUSSEIN M, Inkaya AC, Balci C, Esme M, et al
Frailty and sarcopenia among Turkish people aged 40 and above living with HIV.
HIV Med. 2022 Apr 19. doi: 10.1111/hiv.13311.
PubMed Abstract available

WHITLOCK GG, Ahmed N, Nori A, Richardson D, et al
Characteristics of HIV post-exposure prophylaxis recipients at six English sexual health clinics during COVID-19.
HIV Med. 2022 Apr 10. doi: 10.1111/hiv.13308.
PubMed Abstract available

TANG ME, Gaufin T, Anson R, Zhu W, et al
People with HIV have a higher risk of COVID-19 diagnosis but similar outcomes to the general population.
HIV Med. 2022 Apr 8. doi: 10.1111/hiv.13312.
PubMed Abstract available

DRAK D, Heron JE, Shamu T, Chimbetete C, et al
Predictors of renal impairment and proteinuria after commencement of antiretroviral therapy in a Zimbabwean HIV cohort.
HIV Med. 2022 Apr 8. doi: 10.1111/hiv.13303.
PubMed Abstract available

MOSEHOLM E, Katzenstein TL, Pedersen G, Johansen IS, et al
Use of antiretroviral therapy in pregnancy and association with birth outcome among women living with HIV in Denmark: A nationwide, population-based cohort study.
HIV Med. 2022 Apr 6. doi: 10.1111/hiv.13304.
PubMed Abstract available

LOUW S, Jacobson BF, Wiggill TM, Chapanduka Z, et al
HIV-associated thrombotic thrombocytopenic purpura (HIV-TTP): A practical guide and review of the literature.
HIV Med. 2022 Apr 3. doi: 10.1111/hiv.13305.
PubMed Abstract available

CHIRWA M, Taghinejadi N, Macaulay G, Mandalia S, et al
Reflections on a specialist HIV menopause service: Experiences of managing menopause in women living with HIV: Experiences of managing menopause in women living with HIV.
HIV Med. 2022;23:426-433.
PubMed Abstract available

GILLEECE Y, Sabin CA
Special issue on Women and HIV to mark International Women's Day.
HIV Med. 2022;23:309.
PubMed

BHIVA Spring Conference 2022, Manchester Central, Manchester, UK, 20-22 April 2022.
HIV Med. 2022;23 Suppl 2:3-95.
PubMed

March 2022

TEKALIGN T, Awoke N, Eshetu K, Gelaw Walle B, et al
HIV/AIDS post-exposure prophylaxis knowledge and uptake among health professionals in Africa: Systematic review and meta-analysis.
HIV Med. 2022 Mar 30. doi: 10.1111/hiv.13271.
PubMed Abstract available

CROXFORD S, Emanuel E, Shah A, Chau C, et al
Epidemiology of HIV infection and associated behaviours among people who inject drugs in England, Wales, and Northern Ireland: Nearly 40 years on.
HIV Med. 2022 Mar 30. doi: 10.1111/hiv.13297.
PubMed Abstract available

COCKBAIN B, Whitlock G
Immediate PrEP when accessing PEP: A service evaluation.
HIV Med. 2022 Mar 29. doi: 10.1111/hiv.13310.
PubMed Abstract available

SHANKS G, Shah A, Williams A, Asboe D, et al
Covid-19 First Wave Impact National Survey for HIV Clinicians by Public Health England (PHE), the British HIV Association (BHIVA) and the Children's HIV Association (CHIVA).
HIV Med. 2022 Mar 28. doi: 10.1111/hiv.13307.
PubMed Abstract available

LUU B, Ruderman S, Nance R, Delaney JAC, et al
Tobacco smoking and binge alcohol use are associated with incident venous thromboembolism in an HIV cohort.
HIV Med. 2022 Mar 28. doi: 10.1111/hiv.13309.
PubMed Abstract available

SWANN SA, King EM, Cote HCF, Murray MCM, et al
Stressing the need for validated measures of cortisol in HIV research: A scoping review.
HIV Med. 2022 Mar 27. doi: 10.1111/hiv.13272.
PubMed Abstract available

HENRIQUES BL, Cortez AL, Nunes NN, Vidal JE, et al
Clinical outcomes of HIV-syphilis coinfection among patients with no neurological symptoms: a retrospective cohort study.
HIV Med. 2022 Mar 27. doi: 10.1111/hiv.13306.
PubMed Abstract available

RYOM L, De Miguel R, Cotter AG, Podlekareva D, et al
Major revision version 11.0 of the European AIDS Clinical Society Guidelines 2021.
HIV Med. 2022 Mar 25. doi: 10.1111/hiv.13268.
PubMed Abstract available

ANDERSEN MH, Alexander MT, Bintz C, Ford C, et al
Medically assisted reproduction for people living with HIV in Europe: A cross-country exploratory policy comparison.
HIV Med. 2022 Mar 22. doi: 10.1111/hiv.13269.
PubMed Abstract available

GEDELA K, Rajus N, Luis H, Fridayantara WD, et al
Antiretroviral drug switches to zidovudine-based regimens and loss to follow-up during the first COVID-19 lockdown in Bali, Indonesia.
HIV Med. 2022 Mar 21. doi: 10.1111/hiv.13298.
PubMed Abstract available

FRANGE P, Avettand-Fenoel V, Veber F, Blanche S, et al
No overall impact on body mass index for age change after dolutegravir initiation in a French paediatric cohort.
HIV Med. 2022 Mar 20. doi: 10.1111/hiv.13302.
PubMed Abstract available

LEE KW, Ang CS, Lim SH, Siau CS, et al
Prevalence of mental health conditions among people living with HIV during the COVID-19 pandemic: A rapid systematic review and meta-analysis.
HIV Med. 2022 Mar 18. doi: 10.1111/hiv.13299.
PubMed Abstract available

HE J, Shi R, Duan S, Ye R, et al
Microbial translocation is associated with advanced liver fibrosis among people with HIV.
HIV Med. 2022 Mar 17. doi: 10.1111/hiv.13279.
PubMed Abstract available

PEREZ-VALERO I, Blanch J, Martinez E
Perception of HIV physicians in Spain towards diagnosis and management of neuropsychiatric comorbidities in people with HIV.
HIV Med. 2022 Mar 16. doi: 10.1111/hiv.13296.
PubMed Abstract available

ORKIN C, Cahn P, Castagna A, Emu B, et al
Opening the door on entry inhibitors in HIV: Redefining the use of entry inhibitors in heavily treatment experienced and treatment-limited individuals living with HIV.
HIV Med. 2022 Mar 16. doi: 10.1111/hiv.13288.
PubMed Abstract available

AGUSTI C, Cunillera O, Almeda J, Mascort J, et al
Efficacy of an electronic reminder for HIV screening in primary healthcare based on indicator conditions in Catalonia (Spain).
HIV Med. 2022 Mar 13. doi: 10.1111/hiv.13270.
PubMed Abstract available

CICCONI P, Wells C, McCarthy B, Wareing S, et al
Re-valuation of annual cytology using HPV self-sampling to upgrade prevention (REACH UP): A feasibility study in women living with HIV in the UK.
HIV Med. 2022 Mar 3. doi: 10.1111/hiv.13257.
PubMed Abstract available

RAFFE S, Sabin C, Gilleece Y
Comorbidities in women living with HIV: A systematic review.
HIV Med. 2022 Mar 3. doi: 10.1111/hiv.13240.
PubMed Abstract available

ALVAREZ H, Rava M, Martinez C, Portilla J, et al
Predictors of low-level HIV viraemia and virological failure in the era of integrase inhibitors: A Spanish nationwide cohort.
HIV Med. 2022 Mar 1. doi: 10.1111/hiv.13265.
PubMed Abstract available

BYONANEBYE DM, Polizzotto MN, Neesgaard B, Sarcletti M, et al
Incidence of hypertension in people with HIV who are treated with integrase inhibitors versus other antiretroviral regimens in the RESPOND cohort consortium.
HIV Med. 2022 Mar 1. doi: 10.1111/hiv.13273.
PubMed Abstract available

RAPITI N, Peer N, Abdelatif N, Rapiti P, et al
HIV-associated plasmablastic lymphoma: A single-centre 12-year experience in Kwa-Zulu Natal, South Africa.
HIV Med. 2022 Mar 1. doi: 10.1111/hiv.13266.
PubMed Abstract available

DUAN Y, Zhao H, Tang W, Chen M, et al
Longitudinal analysis of new-onset non-AIDS-defining diseases among people living with HIV: A real-world observational study.
HIV Med. 2022;23 Suppl 1:32-41.
PubMed Abstract available

LI J, Li A, Ye J, Shao Y, et al
Loss to follow-up among human immunodeficiency virus-positive postpartum women and its predictive factors: A retrospective study.
HIV Med. 2022;23 Suppl 1:42-53.
PubMed Abstract available

JIAO YM, Xu Z, Wang FS
Snapshot of clinical problems among people living with HIV in China.
HIV Med. 2022;23 Suppl 1:4-5.
PubMed

HUANG H, Song B, Gao L, Cheng J, et al
Incidence of and risk factors for liver damage in patients with HIV-1 mono-infection receiving antiretroviral therapy.
HIV Med. 2022;23 Suppl 1:14-22.
PubMed Abstract available

MA J, Zheng Q, Zhang H, Wen Y, et al
The spectrum of kidney biopsy findings in Chinese HIV-infected patients.
HIV Med. 2022;23 Suppl 1:23-31.
PubMed Abstract available

NIE J, Deng X, Zeng Q, Du X, et al
Distribution of nontuberculous mycobacteria in patients with and without HIV/AIDS in Chongqing.
HIV Med. 2022;23 Suppl 1:54-63.
PubMed Abstract available

DING H, Xu J, Liu J, Wang Q, et al
Outcomes of persistent low-level viremia among HIV patients on antiretroviral therapy: A prospective cohort study.
HIV Med. 2022;23 Suppl 1:64-71.
PubMed Abstract available

BAI R, Lv S, Hua W, Su B, et al
Factors associated with human immunodeficiency virus-1 low-level viremia and its impact on virological and immunological outcomes: A retrospective cohort study in Beijing, China.
HIV Med. 2022;23 Suppl 1:72-83.
PubMed Abstract available

MIJITI Z, Song JW, Jiao YM, Gao L, et al
alpha4beta7(high) CD4(+) T cells are prone to be infected by HIV-1 and associated with HIV-1 disease progression.
HIV Med. 2022;23 Suppl 1:106-114.
PubMed Abstract available

QIN Y, Song T, Su B, Jiao Y, et al
Comparison of HIV DNA decay and immune recovery between early and chronic HIV-infected individuals 96 weeks after ART.
HIV Med. 2022;23 Suppl 1:6-13.
PubMed Abstract available

GAO L, Xia H, Zeng R, Wu Y, et al
Pre-treatment and acquired antiretroviral drug resistance among people living with HIV in Tianjin, China.
HIV Med. 2022;23 Suppl 1:84-94.
PubMed Abstract available

LIU M, He XQ, Deng RN, Tang SQ, et al
Pretreatment drug resistance in people living with HIV: A large retrospective cohort study in Chongqing, China.
HIV Med. 2022;23 Suppl 1:95-105.
PubMed Abstract available

February 2022

BAISLEY K, Orne-Gliemann J, Larmarange J, Plazy M, et al
Treat-all strategy and long-term survival among people living with HIV in South Africa: Results after 6 years of observation in the ANRS 12249 treatment as prevention trial.
HIV Med. 2022 Feb 26. doi: 10.1111/hiv.13263.
PubMed Abstract available

RUPASINGHE D, Choi JY, Kumarasamy N, Pujari S, et al
Viral hepatitis and the cascade of care among people living with HIV in the Asia-Pacific.
HIV Med. 2022 Feb 25. doi: 10.1111/hiv.13280.
PubMed Abstract available

HULLY A, Mallah R, Villa G, Gilleece Y, et al
Integrating services to improve quality of care for women living with HIV: A global systematic review.
HIV Med. 2022 Feb 24. doi: 10.1111/hiv.13258.
PubMed Abstract available

ROSSETTI B, Fabbiani M, Di Carlo D, Incardona F, et al
Effectiveness of integrase strand transfer inhibitors in HIV-infected treatment-experienced individuals across Europe.
HIV Med. 2022 Feb 24. doi: 10.1111/hiv.13262.
PubMed Abstract available

CERVO A, Sebastiani G, Milic J, Krahn T, et al
"Dangerous liaisons: NAFLD and liver fibrosis increase cardiovascular risk in HIV".
HIV Med. 2022 Feb 24. doi: 10.1111/hiv.13274.
PubMed Abstract available

ODONGPINY ELA, Cresswell F, Arinaitwe A, Nakate V, et al
High willingness to use injectable antiretroviral therapy among women who have been lost to follow-up from HIV programmes: A nested cross-sectional study.
HIV Med. 2022 Feb 23. doi: 10.1111/hiv.13260.
PubMed Abstract available

HACHFELD A, Atkinson A, Stute P, Calmy A, et al
Women with HIV transitioning through menopause: Insights from the Swiss HIV Cohort Study (SHCS).
HIV Med. 2022 Feb 22. doi: 10.1111/hiv.13255.
PubMed Abstract available

LEE MJ, Nori A, Fidler S, Kulasegaram R, et al
Response to 'The use of tenofovir in patients with COVID-19'.
HIV Med. 2022 Feb 22. doi: 10.1111/hiv.13278.
PubMed

LACOMBE-DUNCAN A, Shokoohi M, Persad Y, Underhill A, et al
Short report: Characterizing HIV care among a clinical sample of transgender women living with HIV.
HIV Med. 2022 Feb 22. doi: 10.1111/hiv.13261.
PubMed Abstract available

ASHRAF AN, Okhai H, Sabin CA, Sherr L, et al
Obesity in women living with HIV aged 45-60 in England: An analysis of the PRIME study.
HIV Med. 2022 Feb 18. doi: 10.1111/hiv.13242.
PubMed Abstract available

COURVOISIER N, Storari C, Lesage S, Vittoz L, et al
Facilitators and barriers of women's participation in HIV clinical research in Switzerland: A qualitative study.
HIV Med. 2022 Feb 18. doi: 10.1111/hiv.13259.
PubMed Abstract available

RASI V, Peters H, Sconza R, Francis K, et al
Trends in antiretroviral use in pregnancy in the UK and Ireland, 2008-2018.
HIV Med. 2022 Feb 18. doi: 10.1111/hiv.13243.
PubMed Abstract available

CRESSWELL F, Asanati K, Bhagani S, Boffito M, et al
UK guideline for the use of HIV post-exposure prophylaxis 2021.
HIV Med. 2022 Feb 14. doi: 10.1111/hiv.13208.
PubMed Abstract available

GUPTA R, Kaur A, Sandeep, Singh S, et al
Anal cytological abnormalities and human papillomavirus infection in women living with HIV: A systematic review and meta-analysis.
HIV Med. 2022 Feb 12. doi: 10.1111/hiv.13227.
PubMed Abstract available

HANNA J, Sufian J, Suh JS, Jimenez HR, et al
Hepatitis Cvirusmicro-elimination within a clinic for people with HIV:challenges in thehomestretch.
HIV Med. 2022 Feb 12. doi: 10.1111/hiv.13241.
PubMed Abstract available

INCEER M, Brouillette MJ, Fellows LK, Morais JA, et al
Factors partitioning physical frailty in people aging with HIV: A classification and regression tree approach.
HIV Med. 2022 Feb 1. doi: 10.1111/hiv.13236.
PubMed Abstract available

January 2022

WENLOCK RD, Shillingford C, Mear J, Churchill D, et al
The impact of COVID-19 on HIV testing in the UK's first Fast-Track HIV city.
HIV Med. 2022 Jan 30. doi: 10.1111/hiv.13235.
PubMed Abstract available

WAHOME E, Boyd A, Thiong'o AN, Mohamed K, et al
Stopping and restarting PrEP and loss to follow-up among PrEP-taking men who have sex with men and transgender women at risk of HIV-1 participating in a prospective cohort study in Kenya.
HIV Med. 2022 Jan 27. doi: 10.1111/hiv.13237.
PubMed Abstract available

AVELINO-SILVA VI, Vasconcelos R, Cerqueira NB, Marcus U, et al
Predictors of knowledge of and access to biomedical prevention among MSM and transgender men in Latin America: Results from the Latin American internet survey.
HIV Med. 2022 Jan 23. doi: 10.1111/hiv.13238.
PubMed Abstract available

ADLER Z, Fitzpatrick C, Broadwell N, Churchill D, et al
Chemsex and antiretroviral prescribing in an HIV cohort in Brighton, UK.
HIV Med. 2022 Jan 20. doi: 10.1111/hiv.13239.
PubMed Abstract available

FANCIULLI C, Berenguer J, Busca C, Vivancos MJ, et al
Epidemiological trends of HIV/HCV coinfection in Spain, 2015-2019.
HIV Med. 2022 Jan 17. doi: 10.1111/hiv.13229.
PubMed Abstract available

BRIJKUMAR J, Edwards JA, Johnson BA, Ordonez C, et al
Comparing effectiveness of first-line antiretroviral therapy between peri-urban and rural clinics in KwaZulu-Natal, South Africa.
HIV Med. 2022 Jan 12. doi: 10.1111/hiv.13231.
PubMed Abstract available

AFFI R, Gabillard D, Kouame GM, Ntakpe JB, et al
Plasma sVCAM-1, antiretroviral therapy and mortality in HIV-1-infected West African adults.
HIV Med. 2022 Jan 12. doi: 10.1111/hiv.13230.
PubMed Abstract available

KOW CS, Ramachandram DS, Hasan SS
The use of tenofovir in patients with COVID-19.
HIV Med. 2022 Jan 12. doi: 10.1111/hiv.13228.
PubMed

HARDING R, Jones CI, Bremner S, Bristowe K, et al
Positive Outcomes: Validity, reliability and responsiveness of a novel person-centred outcome measure for people with HIV.
HIV Med. 2022 Jan 11. doi: 10.1111/hiv.13224.
PubMed Abstract available

SABIN C
A new year, and big changes for HIV Medicine.
HIV Med. 2022;23:3.
PubMed

December 2021

VAN LETTOW M, Tippett Barr BA, van Oosterhout JJ, Schouten E, et al
The National Evaluation of Malawi's PMTCT Program (NEMAPP) study: 24-month HIV-exposed infant outcomes from a prospective cohort study.
HIV Med. 2021 Dec 30. doi: 10.1111/hiv.13209.
PubMed Abstract available

NDEGE RC, Okuma J, Kalinjuma AV, Mkumbo J, et al
Failure to return pillbox is a predictor of being lost to follow-up among people living with HIV on antiretroviral therapy in rural Tanzania.
HIV Med. 2021 Dec 28. doi: 10.1111/hiv.13223.
PubMed Abstract available

MARQUES-GOMES J, Salt MJ, Pereira-Neto R, Barteldes FS, et al
Development of the HIV360 international core set of outcome measures for adults living with HIV: A consensus process.
HIV Med. 2021 Dec 28. doi: 10.1111/hiv.13221.
PubMed Abstract available

FOKAM J, Mpouel Bala ML, Santoro MM, Takou D, et al
Archiving of mutations in HIV-1 cellular reservoirs among vertically infected adolescents is contingent with clinical stages and plasma viral load: Evidence from the EDCTP-READY study.
HIV Med. 2021 Dec 23. doi: 10.1111/hiv.13220.
PubMed Abstract available

WILLIS SJ, Kim HN, Achenbach CJ, Cachay ER, et al
Hepatitis C coinfection and extrahepatic cancer incidence among people living with HIV.
HIV Med. 2021 Dec 23. doi: 10.1111/hiv.13218.
PubMed Abstract available

WHITE HA, Okhai H, Kirwan P, Rafeeq SH, et al
Tuberculosis incidence in country of origin is a key determinant of the risk of active tuberculosis in people living with HIV: Data from a 30-year observational cohort study.
HIV Med. 2021 Dec 22. doi: 10.1111/hiv.13222.
PubMed Abstract available

MUIRU AN, Madden E, Chilingirian A, Rubinsky AD, et al
The incidence of and risk factors for hospitalized acute kidney injury among people living with HIV on antiretroviral treatment.
HIV Med. 2021 Dec 12. doi: 10.1111/hiv.13216.
PubMed Abstract available

MOCROFT A, Miro JM, Wandeler G, Llibre JM, et al
The association between hepatitis B virus infection and nonliver malignancies in persons living with HIV: results from the EuroSIDA study.
HIV Med. 2021 Dec 9. doi: 10.1111/hiv.13210.
PubMed Abstract available

AMELE S, Sandri AK, Rodger A, Vandekerckhove L, et al
HCV reinfection after HCV therapy among HIV/HCV-coinfected individuals in Europe.
HIV Med. 2021 Dec 9. doi: 10.1111/hiv.13212.
PubMed Abstract available

CAMPBELL L, Ibrahim F, Barbini B, Samarawickrama A, et al
Bone mineral density, kidney function and participant-reported outcome measures in women who switch from tenofovir disoproxil emtricitabine and a nonnucleoside reverse transcriptase inhibitor to abacavir, lamivudine and dolutegravir.
HIV Med. 2021 Dec 5. doi: 10.1111/hiv.13215.
PubMed Abstract available

LAKATOS B, Kowalska J, Antoniak S, Gokengin D, et al
Retrospective evaluation of an observational cohort by the Central and Eastern Europe Network Group shows a high frequency of potential drug-drug interactions among HIV-positive patients receiving treatment for coronavirus disease 2019 (COVID-19).
HIV Med. 2021 Dec 3. doi: 10.1111/hiv.13214.
PubMed Abstract available

KAEWPOOWAT Q, Rerkasem A, Rerkasem K, Robertson KR, et al
Cardio-ankle vascular index of increased arterial wall stiffness is associated with neurocognitive impairment in well-controlled HIV.
HIV Med. 2021 Dec 3. doi: 10.1111/hiv.13213.
PubMed Abstract available

REEVES I, Cromarty B, Deayton J, Dhairyawan R, et al
British HIV Association guidelines for the management of HIV-2 2021.
HIV Med. 2021;22 Suppl 4:1-29.
PubMed

November 2021

NAITO T, Suzuki M, Fukushima S, Yuda M, et al
Comorbidities and co-medications among 28 089 people living with HIV: A nationwide cohort study from 2009 to 2019 in Japan.
HIV Med. 2021 Nov 25. doi: 10.1111/hiv.13206.
PubMed Abstract available

HAN WM, Law MG, Choi JY, Ditangco R, et al
Weight changes, metabolic syndrome and all-cause mortality among Asian adults living with HIV.
HIV Med. 2021 Nov 23. doi: 10.1111/hiv.13211.
PubMed Abstract available

KADDU-MULINDWA D, Keuser L, Lesan V, Rissland J, et al
IgG seroprevalence of COVID-19 among people living with HIV or at high risk of HIV in south-west Germany: A seroprevalence study.
HIV Med. 2021 Nov 22. doi: 10.1111/hiv.13207.
PubMed Abstract available

TARIQ S, Okhai H, Severn A, Sabin CA, et al
Follicle-stimulating hormone in postmenopausal women living with HIV: a prevalence study.
HIV Med. 2021 Nov 17. doi: 10.1111/hiv.13205.
PubMed Abstract available

REYNOLDS Z, McCluskey SM, Moosa MYS, Gilbert RF, et al
Who's slipping through the cracks? A comprehensive individual, clinical and health system characterization of people with virological failure on first-line HIV treatment in Uganda and South Africa.
HIV Med. 2021 Nov 9. doi: 10.1111/hiv.13203.
PubMed Abstract available

CUZIN L, Delobel P, Martin-Blondel G
Letter to the editor.
HIV Med. 2021 Nov 7. doi: 10.1111/hiv.13192.
PubMed

O'NEIL PJ, Stafford KA, Ryscavage PA
Assessing risk factors for hypertension in young adults with perinatally acquired HIV infection: A case-control study.
HIV Med. 2021 Nov 2. doi: 10.1111/hiv.13199.
PubMed Abstract available

SILVA-NASH J, Bordelon S, Searcy SA, Dare RK, et al
Standardizing HIV post-exposure prophylaxis in the emergency department following sexual assault.
HIV Med. 2021 Nov 2. doi: 10.1111/hiv.13196.
PubMed Abstract available

JEDICKE N, Stankov MV, Cossmann A, Dopfer-Jablonka A, et al
Humoral immune response following prime and boost BNT162b2 vaccination in people living with HIV on antiretroviral therapy.
HIV Med. 2021 Nov 2. doi: 10.1111/hiv.13202.
PubMed Abstract available

RICHARDSON D, Nichols K, Hughes R, Smith H, et al
The characteristics of men who have sex with men (MSM) using post-exposure prophylaxis for sexual exposure (PEPSE) in the pre-exposure prophylaxis (PrEP) era.
HIV Med. 2021 Nov 2. doi: 10.1111/hiv.13201.
PubMed Abstract available

October 2021

CASTILLO-MANCILLA JR, Musinguzi N, Asiimwe S, Siedner MJ, et al
High residual inflammation despite HIV viral suppression: Lessons learned from real-time adherence monitoring among people with HIV in Africa.
HIV Med. 2021 Oct 26. doi: 10.1111/hiv.13200.
PubMed Abstract available

JILICH D, Skrzat-Klapaczynska A, Fleischhans L, Bursa D, et al
National strategies for vaccination against COVID-19 in people living with HIV in Central and Eastern European region.
HIV Med. 2021 Oct 26. doi: 10.1111/hiv.13194.
PubMed Abstract available

LARSON D, Won SH, Ganesan A, Maves RC, et al
Statin usage and cardiovascular risk among people living with HIV in the U.S. Military HIV Natural History Study.
HIV Med. 2021 Oct 26. doi: 10.1111/hiv.13195.
PubMed Abstract available

JONES HT, Samji A, Cope N, Williams J, et al
What problems associated with ageing are seen in a specialist service for older people living with HIV?
HIV Med. 2021 Oct 25. doi: 10.1111/hiv.13193.
PubMed Abstract available

CORKER E, Lorencatto F, Anderson N, Gobin M, et al
Acceptability and facilitators of and barriers to point-of-care HIV testing in a homeless-focused service in Gloucestershire: a qualitative evaluation.
HIV Med. 2021 Oct 24. doi: 10.1111/hiv.13187.
PubMed Abstract available

LAJAUNIE R, Cuzin L, Palich R, Makinson A, et al
No increased risk of Kaposi sarcoma relapse in patients with controlled HIV-1 infection after switching protease inhibitor-based antiretroviral therapy.
HIV Med. 2021 Oct 19. doi: 10.1111/hiv.13168.
PubMed Abstract available

SILVERSTEIN A, Kamiyango W, Villiera J, Peckham-Gregory EC, et al
Long-term outcomes for children and adolescents with Kaposi sarcoma.
HIV Med. 2021 Oct 11. doi: 10.1111/hiv.13191.
PubMed Abstract available

VASCONCELOS R, Avelino-Silva VI, de Paula IA, Jamal LF, et al
HIV self-test: a tool to expand test uptake among men who have sex with men who have never been tested for HIV in Sao Paulo, Brazil.
HIV Med. 2021 Oct 11. doi: 10.1111/hiv.13178.
PubMed Abstract available

NITPOLPRASERT C, Anand T, Phanuphak N, Reiss P, et al
A qualitative study of the impact of coronavirus disease (COVID-19) on psychological and financial wellbeing and engagement in care among men who have sex with men living with HIV in Thailand.
HIV Med. 2021 Oct 11. doi: 10.1111/hiv.13190.
PubMed Abstract available

JONES TPW, Lampe FC, Arenas-Pinto A, Smith C, et al
Alcohol, smoking, recreational drug use and association with virological outcomes among people living with HIV: cross-sectional and longitudinal analyses.
HIV Med. 2021 Oct 11. doi: 10.1111/hiv.13156.
PubMed Abstract available

BURNS JE, Stirrup O, Waters L, Dunn D, et al
No overall impact on rate of weight gain with integrase inhibitor-containing regimens in antiretroviral-naive adults.
HIV Med. 2021 Oct 11. doi: 10.1111/hiv.13186.
PubMed Abstract available

TUAN JJ, Zapata H, Critch-Gilfillan T, Ryall L, et al
Qualitative assessment of anti-SARS-CoV-2 spike protein immunogenicity (QUASI) after COVID-19 vaccination in older people living with HIV.
HIV Med. 2021 Oct 10. doi: 10.1111/hiv.13188.
PubMed Abstract available

RICK F, Odoke W, van den Hombergh J, Benzaken AS, et al
Impact of coronavirus disease (COVID-19) on HIV testing and care provision across four continents.
HIV Med. 2021 Oct 10. doi: 10.1111/hiv.13180.
PubMed Abstract available

BROWN JA, Nsakala BL, Mokhele K, Rakuoane I, et al
Viral suppression after transition from nonnucleoside reverse transcriptase inhibitor- to dolutegravir-based antiretroviral therapy: A prospective cohort study in Lesotho (DO-REAL study).
HIV Med. 2021 Oct 10. doi: 10.1111/hiv.13189.
PubMed Abstract available

TUFA TB, Fuchs A, Orth HM, Lubke N, et al
Characterization of HIV-1 drug resistance among patients with failure of second-line combined antiretroviral therapy in central Ethiopia.
HIV Med. 2021 Oct 7. doi: 10.1111/hiv.13176.
PubMed Abstract available

HOVAGUIMIAN F, Martin E, Reinacher M, Rasi M, et al
Participation, retention and uptake in a multicentre pre-exposure prophylaxis cohort using online, smartphone-compatible data collection.
HIV Med. 2021 Oct 3. doi: 10.1111/hiv.13175.
PubMed Abstract available

CHAPPELL E, Kohns Vasconcelos M, Goodall RL, Galli L, et al
Children living with HIV in Europe: do migrants have worse treatment outcomes?
HIV Med. 2021 Oct 1. doi: 10.1111/hiv.13177.
PubMed Abstract available

Abstracts of the 18th European AIDS Conference (EACS 2021), Online & London, United Kingdom, October 27-30, 2021.
HIV Med. 2021;22 Suppl 3:4-309.
PubMed

September 2021

GRIMSHAW C, Boyd L, Smith M, Estcourt CS, et al
Evaluation of an inner city HIV pre-exposure prophylaxis service tailored to the needs of people who inject drugs.
HIV Med. 2021 Sep 28. doi: 10.1111/hiv.13181.
PubMed Abstract available

WONG IKJ, Grulich AE, Poynten IM, Polizzotto MN, et al
Time trends in cancer incidence in Australian people living with HIV between 1982 and 2012.
HIV Med. 2021 Sep 28. doi: 10.1111/hiv.13179.
PubMed Abstract available

January 2021

SABIN CA, Kunisaki KM, Bagkeris E, Post FA, et al
Respiratory symptoms and chronic bronchitis in people with and without HIV infection.
HIV Med. 2021;22:11-21.
PubMed Abstract available

LEEME TB, Mine M, Lechiile K, Mulenga F, et al
Utility of CD4 count measurement in the era of universal antiretroviral therapy: an analysis of routine laboratory data in Botswana.
HIV Med. 2021;22:1-10.
PubMed Abstract available

BOEKE CE, Khan S, Walsh F, Hettema A, et al
Universal test and treat in relation to HIV disease progression: results from a stepped-wedge trial in Eswatini.
HIV Med. 2021;22:54-59.
PubMed Abstract available

September 2020

RYOM L, Cotter A, De Miguel R, Beguelin C, et al
2019 update of the European AIDS Clinical Society Guidelines for treatment of people living with HIV version 10.0.
HIV Med. 2020 Sep 3. doi: 10.1111/hiv.12878.
PubMed Abstract available

GIROMETTI N, Lander F, McOwan A, Nwokolo N, et al
Rapid ART start in early HIV infection: Time to viral load suppression and retention in care in a London cohort.
HIV Med. 2020 Sep 1. doi: 10.1111/hiv.12900.
PubMed Abstract available

July 2020

OKOLI C, Schwenk A, Radford M, Myland M, et al
Polypharmacy and potential drug-drug interactions for people with HIV in the UK from the Climate-HIV database.
HIV Med. 2020 Jul 15. doi: 10.1111/hiv.12879.
PubMed Abstract available

June 2020

MWASAKIFWA GE, Amin J, White CP, Center JR, et al
Early changes in bone turnover and inflammatory biomarkers and clinically significant bone mineral density loss over 48 weeks among HIV-infected patients with virological failure of a standard first-line antiretroviral therapy regimen in the SECOND-LI
HIV Med. 2020 Jun 23. doi: 10.1111/hiv.12882.
PubMed Abstract available

GANTNER P, Allavena C, Duvivier C, Cabie A, et al
Post-exposure prophylaxis completion and condom use in the context of potential sexual exposure to HIV.
HIV Med. 2020 Jun 17. doi: 10.1111/hiv.12880.
PubMed Abstract available

SCHRADER SY, Zeder AJ, Hilge R, Bogner JR, et al
Medium-grade proteinuria is a risk factor for incident markers of chronic kidney disease.
HIV Med. 2020 Jun 17. doi: 10.1111/hiv.12881.
PubMed Abstract available

February 2020

SCHWARZE-ZANDER C, Piduhn H, Boesecke C, Schlabe S, et al
Switching tenofovir disoproxil fumarate to tenofovir alafenamide in a real life setting: what are the implications?
HIV Med. 2020 Feb 17. doi: 10.1111/hiv.12840.
PubMed Abstract available

January 2020

STIRRUP OT, Asboe D, Pozniak A, Sabin CA, et al
Continuation of emtricitabine/lamivudine within combination antiretroviral therapy following detection of the M184V/I HIV-1 resistance mutation.
HIV Med. 2020 Jan 11. doi: 10.1111/hiv.12829.
PubMed Abstract available

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge.